327897662021063020210722
1432-201347292020SepPflugers Archiv : European journal of physiologyPflugers ArchGlucose transporters in brain in health and disease.129913431299-134310.1007/s00424-020-02441-xEnergy demand of neurons in brain that is covered by glucose supply from the blood is ensured by glucose transporters in capillaries and brain cells. In brain, the facilitative diffusion glucose transporters GLUT1-6 and GLUT8, and the Na+-D-glucose cotransporters SGLT1 are expressed. The glucose transporters mediate uptake of D-glucose across the blood-brain barrier and delivery of D-glucose to astrocytes and neurons. They are critically involved in regulatory adaptations to varying energy demands in response to differing neuronal activities and glucose supply. In this review, a comprehensive overview about verified and proposed roles of cerebral glucose transporters during health and diseases is presented. Our current knowledge is mainly based on experiments performed in rodents. First, the functional properties of human glucose transporters expressed in brain and their cerebral locations are described. Thereafter, proposed physiological functions of GLUT1, GLUT2, GLUT3, GLUT4, and SGLT1 for energy supply to neurons, glucose sensing, central regulation of glucohomeostasis, and feeding behavior are compiled, and their roles in learning and memory formation are discussed. In addition, diseases are described in which functional changes of cerebral glucose transporters are relevant. These are GLUT1 deficiency syndrome (GLUT1-SD), diabetes mellitus, Alzheimer's disease (AD), stroke, and traumatic brain injury (TBI). GLUT1-SD is caused by defect mutations in GLUT1. Diabetes and AD are associated with changed expression of glucose transporters in brain, and transporter-related energy deficiency of neurons may contribute to pathogenesis of AD. Stroke and TBI are associated with changes of glucose transporter expression that influence clinical outcome.KoepsellHermannH0000-0001-5118-7088Institute for Anatomy and Cell Biology, University of Würzburg, Koellikerstr 6, 97070, Würzburg, Germany. Hermann@Koepsell.de.engJournal ArticleResearch Support, Non-U.S. Gov'tReview20200813
GermanyPflugers Arch01547200031-67680Glucose Transport Proteins, Facilitative0Monosaccharide Transport ProteinsGlut1 Deficiency SyndromeIMAlzheimer DiseasemetabolismAnimalsBrainmetabolismCarbohydrate Metabolism, Inborn ErrorsmetabolismDiabetes MellitusmetabolismGlucose Transport Proteins, FacilitativegeneticsmetabolismHumansMonosaccharide Transport ProteinsdeficiencymetabolismBrainDiabetesGLUT1GLUT1 deficiency syndromeGLUT2GLUT3GLUT4Glucose transporterParkinson’s diseaseSGLT1StrokeTraumatic brain injury20207220207242020720202081460202171602020814602020813ppublish32789766PMC746293110.1007/s00424-020-02441-x10.1007/s00424-020-02441-xAgus DB, Gambhir SS, Pardridge WM, Spielholz C, Baselga J, Vera JC, Golde DW. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest. 1997;100:2842–2848. doi: 10.1172/JCI119832.10.1172/JCI119832PMC5084909389750Akman CI, Provenzano F, Wang D, Engelstad K, Hinton V, Yu J, Tikofsky R, Ichese M, De Vivo DC. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency. Epilepsy Res. 2015;110:206–215. doi: 10.1016/j.eplepsyres.2014.11.007.10.1016/j.eplepsyres.2014.11.00725616474Al Feteisi H, Al-Majdoub ZM, Achour B, Couto N, Rostami-Hodjegan A, Barber J. Identification and quantification of blood-brain barrier transporters in isolated rat brain microvessels. J Neurochem. 2018;146:670–685. doi: 10.1111/jnc.14446.10.1111/jnc.1444629675872Alata W, Ye Y, St-Amour I, Vandal M, Calon F. Human apolipoprotein E varepsilon4 expression impairs cerebral vascularization and blood-brain barrier function in mice. J Cereb Blood Flow Metab. 2015;35:86–94. doi: 10.1038/jcbfm.2014.172.10.1038/jcbfm.2014.172PMC429657425335802Aljure O, Diez-Sampedro A. Functional characterization of mouse sodium/glucose transporter type 3b. Am J Physiol Cell Physiol. 2010;299:C58–C65. doi: 10.1152/ajpcell.00030.2010.10.1152/ajpcell.00030.201020392930Allen A, Messier C. Plastic changes in the astrocyte GLUT1 glucose transporter and beta-tubulin microtubule protein following voluntary exercise in mice. Behav Brain Res. 2013;240:95–102. doi: 10.1016/j.bbr.2012.11.025.10.1016/j.bbr.2012.11.02523201358Alvarez JI, Katayama T, Prat A. Glial influence on the blood brain barrier. Glia. 2013;61:1939–1958. doi: 10.1002/glia.22575.10.1002/glia.22575PMC406828124123158Amalou S, Gras D, Ilea A, Greneche MO, Francois L, Bellavoine V, Delanoe C, Auvin S. Use of modified Atkins diet in glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol. 2016;58:1193–1199. doi: 10.1111/dmcn.13167.10.1111/dmcn.1316727273526An J, Haile WB, Wu F, Torre E, Yepes M. Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system. Neuroscience. 2014;257:41–48. doi: 10.1016/j.neuroscience.2013.10.060.10.1016/j.neuroscience.2013.10.060PMC388907124200922Anand BK, Chhina GS, Sharma KN, Dua S, Singh B. Activity of single neurons in the hypothalamic feeding centers: effect of glucose. Am J Phys. 1964;207:1146–1154. doi: 10.1152/ajplegacy.1964.207.5.1146.10.1152/ajplegacy.1964.207.5.114614237464Apelt J, Mehlhorn G, Schliebs R. Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. J Neurosci Res. 1999;57:693–705.10462693Arluison M, Quignon M, Nguyen P, Thorens B, Leloup C, Penicaud L. Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain--an immunohistochemical study. J Chem Neuroanat. 2004;28:117–136. doi: 10.1016/j.jchemneu.2004.05.009.10.1016/j.jchemneu.2004.05.00915482899Arluison M, Quignon M, Thorens B, Leloup C, Penicaud L. Immunocytochemical localization of the glucose transporter 2 (GLUT2) in the adult rat brain. II. Electron microscopic study. J Chem Neuroanat. 2004;28:137–146. doi: 10.1016/j.jchemneu.2004.06.002.10.1016/j.jchemneu.2004.06.00215482900Armstrong RA. A critical analysis of the 'amyloid cascade hypothesis'. Folia Neuropathol. 2014;52:211–225.25310732Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, Bang S, Choi BR, Chen Y, McMullen MF, Kim SF. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis. 2014;67:79–87. doi: 10.1016/j.nbd.2014.03.011.10.1016/j.nbd.2014.03.011PMC408306024686304Ashrafi G, Wu Z, Farrell RJ, Ryan TA. GLUT4 mobilization supports energetic demands of active synapses. Neuron. 2017;93:606–615 e603. doi: 10.1016/j.neuron.2016.12.020.10.1016/j.neuron.2016.12.020PMC533025728111082Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke. 1981;12:723–725. doi: 10.1161/01.str.12.6.723.10.1161/01.str.12.6.7236272455Augustin R, Riley J, Moley KH. GLUT8 contains a [DE]XXXL[LI] sorting motif and localizes to a late endosomal/lysosomal compartment. Traffic. 2005;6:1196–1212. doi: 10.1111/j.1600-0854.2005.00354.x.10.1111/j.1600-0854.2005.00354.x16262729Badr GA, Tang J, Ismail-Beigi F, Kern TS. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes. 2000;49:1016–1021. doi: 10.2337/diabetes.49.6.1016.10.2337/diabetes.49.6.101610866055Bady I, Marty N, Dallaporta M, Emery M, Gyger J, Tarussio D, Foretz M, Thorens B. Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding. Diabetes. 2006;55:988–995. doi: 10.2337/diabetes.55.04.06.db05-1386.10.2337/diabetes.55.04.06.db05-138616567520Bakirtzi K, Belfort G, Lopez-Coviella I, Kuruppu D, Cao L, Abel ED, Brownell AL, Kandror KV. Cerebellar neurons possess a vesicular compartment structurally and functionally similar to Glut4-storage vesicles from peripheral insulin-sensitive tissues. J Neurosci. 2009;29:5193–5201. doi: 10.1523/JNEUROSCI.0858-09.2009.10.1523/JNEUROSCI.0858-09.2009PMC269217519386915Balen D, Ljubojevic M, Breljak D, Brzica H, Zlender V, Koepsell H, Sabolic I. Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody. Am J Physiol Cell Physiol. 2008;295:C475–C489.18524944Banks WA, Owen JB, Erickson MA. Insulin in the brain: there and back again. Pharmacol Ther. 2012;136:82–93. doi: 10.1016/j.pharmthera.2012.07.006.10.1016/j.pharmthera.2012.07.006PMC413467522820012Barahona MJ, Llanos P, Recabal A, Escobar-Acuna K, Elizondo-Vega R, Salgado M, Ordenes P, Uribe E, Sepulveda FJ, Araneda RC, Garcia-Robles MA. Glial hypothalamic inhibition of GLUT2 expression alters satiety, impacting eating behavior. Glia. 2018;66:592–605. doi: 10.1002/glia.23267.10.1002/glia.23267PMC581488429178321Barcelona S, Menegaz D, Diez-Sampedro A. Mouse SGLT3a generates proton-activated currents but does not transport sugar. Am J Physiol Cell Physiol. 2012;302:C1073–C1082. doi: 10.1152/ajpcell.00436.2011.10.1152/ajpcell.00436.201122301059Barros LF, San Martin A, Ruminot I, Sandoval PY, Fernandez-Moncada I, Baeza-Lehnert F, Arce-Molina R, Contreras-Baeza Y, Cortes-Molina F, Galaz A, Alegria K. Near-critical GLUT1 and neurodegeneration. J Neurosci Res. 2017;95:2267–2274. doi: 10.1002/jnr.23998.10.1002/jnr.2399828150866Barzo P, Marmarou A, Fatouros P, Hayasaki K, Corwin F. Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg. 1997;87:900–907. doi: 10.3171/jns.1997.87.6.0900.10.3171/jns.1997.87.6.09009384402Benarroch EE. Brain glucose transporters: implications for neurologic disease. Neurology. 2014;82:1374–1379.24647029Benford H, Bolborea M, Pollatzek E, Lossow K, Hermans-Borgmeyer I, Liu B, Meyerhof W, Kasparov S, Dale N. A sweet taste receptor-dependent mechanism of glucosensing in hypothalamic tanycytes. Glia. 2017;65:773–789. doi: 10.1002/glia.23125.10.1002/glia.23125PMC536335728205335Benomar Y, Naour N, Aubourg A, Bailleux V, Gertler A, Djiane J, Guerre-Millo M, Taouis M. Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase- dependent mechanism. Endocrinology. 2006;147:2550–2556. doi: 10.1210/en.2005-1464.10.1210/en.2005-146416497805Bergersen L, Waerhaug O, Helm J, Thomas M, Laake P, Davies AJ, Wilson MC, Halestrap AP, Ottersen OP. A novel postsynaptic density protein: the monocarboxylate transporter MCT2 is co-localized with delta-glutamate receptors in postsynaptic densities of parallel fiber-Purkinje cell synapses. Exp Brain Res. 2001;136:523–534. doi: 10.1007/s002210000600.10.1007/s00221000060011291733Bergsneider M, Hovda DA, Shalmon E, Kelly DF, Vespa PM, Martin NA, Phelps ME, McArthur DL, Caron MJ, Kraus JF, Becker DP. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg. 1997;86:241–251. doi: 10.3171/jns.1997.86.2.0241.10.3171/jns.1997.86.2.02419010426Biessels GJ, Kamal A, Ramakers GM, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes. 1996;45:1259–1266. doi: 10.2337/diab.45.9.1259.10.2337/diab.45.9.12598772732Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res. 1998;800:125–135. doi: 10.1016/s0006-8993(98)00510-1.10.1016/s0006-8993(98)00510-19685609Bittner CX, Valdebenito R, Ruminot I, Loaiza A, Larenas V, Sotelo-Hitschfeld T, Moldenhauer H, San Martin A, Gutierrez R, Zambrano M, Barros LF. Fast and reversible stimulation of astrocytic glycolysis by K+ and a delayed and persistent effect of glutamate. J Neurosci. 2011;31:4709–4713. doi: 10.1523/JNEUROSCI.5311-10.2011.10.1523/JNEUROSCI.5311-10.2011PMC662291621430169Blonz ER. Alzheimer’s disease as the product of a progressive energy deficiency syndrome in the central nervous system: the neuroenergetic hypothesis. J Alzheimers Dis. 2017;60:1223–1229. doi: 10.3233/JAD-170549.10.3233/JAD-170549PMC567697928946565Boado RJ, Wu D, Windisch M. In vivo upregulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived peptides. Neurosci Res. 1999;34:217–224.10576544Boccia MM, Kopf SR, Baratti CM. Phlorizin, a competitive inhibitor of glucose transport, facilitates memory storage in mice. Neurobiol Learn Mem. 1999;71:104–112. doi: 10.1006/nlme.1998.3856.10.1006/nlme.1998.38569889076Bolz S, Farrell CL, Dietz K, Wolburg H. Subcellular distribution of glucose transporter (GLUT-1) during development of the blood-brain barrier in rats. Cell Tissue Res. 1996;284:355–365. doi: 10.1007/s004410050596.10.1007/s0044100505968646755Bondy CA, Lee WH, Zhou J. Ontogeny and cellular distribution of brain glucose transporter gene expression. Mol Cell Neurosci. 1992;3:305–314. doi: 10.1016/1044-7431(92)90027-y.10.1016/1044-7431(92)90027-y19912873Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes. 1995;44:180–184. doi: 10.2337/diab.44.2.180.10.2337/diab.44.2.1807859938Boychuk CR, Gyarmati P, Xu H, Smith BN. Glucose sensing by GABAergic neurons in the mouse nucleus tractus solitarii. J Neurophysiol. 2015;114:999–1007. doi: 10.1152/jn.00310.2015.10.1152/jn.00310.2015PMC472510326084907Brant AM, Jess TJ, Milligan G, Brown CM, Gould GW. Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. Biochem Biophys Res Commun. 1993;192:1297–1302. doi: 10.1006/bbrc.1993.1557.10.1006/bbrc.1993.15578507199Brightman MW, Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol. 1969;40:648–677. doi: 10.1083/jcb.40.3.648.10.1083/jcb.40.3.648PMC21076505765759Brockmann K. The expanding phenotype of GLUT1-deficiency syndrome. Brain and Development. 2009;31:545–552. doi: 10.1016/j.braindev.2009.02.008.10.1016/j.braindev.2009.02.00819304421Brun A, Englund E. Regional pattern of degeneration in Alzheimer’s disease: neuronal loss and histopathological grading. Histopathology. 1981;5:549–564. doi: 10.1111/j.1365-2559.1981.tb01818.x.10.1111/j.1365-2559.1981.tb01818.x7286917Buee L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM. Pathological alterations of the cerebral microvasculature in Alzheimer’s disease and related dementing disorders. Acta Neuropathol. 1994;87:469–480. doi: 10.1007/BF00294173.10.1007/BF002941738059599Bulboaca A, S DB, Suci S. Protective effect of curcumin in fructose-induced metabolic syndrome and in streptozotocin-induced diabetes in rats. Iran J Basic Med Sci. 2016;19:585–593.PMC495159627482338Burant CF, Bell GI. Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins. Biochemistry. 1992;31:10414–10420.1420159Burant CF, Takeda J, Brot-Laroche E, Bell GI, Davidson NO. Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem. 1992;267:14523–14526.1634504Burdakov D, Luckman SM, Verkhratsky A. Glucose-sensing neurons of the hypothalamus. Philos Trans R Soc Lond Ser B Biol Sci. 2005;360:2227–2235. doi: 10.1098/rstb.2005.1763.10.1098/rstb.2005.1763PMC156959816321792Burdakov D, Jensen LT, Alexopoulos H, Williams RH, Fearon IM, O'Kelly I, Gerasimenko O, Fugger L, Verkhratsky A. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron. 2006;50:711–722. doi: 10.1016/j.neuron.2006.04.032.10.1016/j.neuron.2006.04.03216731510Byrne FL, Poon IK, Modesitt SC, Tomsig JL, Chow JD, Healy ME, Baker WD, Atkins KA, Lancaster JM, Marchion DC, Moley KH, Ravichandran KS, Slack-Davis JK, Hoehn KL. Metabolic vulnerabilities in endometrial cancer. Cancer Res. 2014;74:5832–5845. doi: 10.1158/0008-5472.CAN-14-0254.10.1158/0008-5472.CAN-14-025425205105Byrne FL, Olzomer EM, Brink R, Hoehn KL. Knockout of glucose transporter GLUT6 has minimal effects on whole body metabolic physiology in mice. Am J Physiol Endocrinol Metab. 2018;315:E286–E293. doi: 10.1152/ajpendo.00082.2018.10.1152/ajpendo.00082.201829664675Caesar K, Hashemi P, Douhou A, Bonvento G, Boutelle MG, Walls AB, Lauritzen M. Glutamate receptor-dependent increments in lactate, glucose and oxygen metabolism evoked in rat cerebellum in vivo. J Physiol. 2008;586:1337–1349. doi: 10.1113/jphysiol.2007.144154.10.1113/jphysiol.2007.144154PMC237566318187464Cao D, Lu H, Lewis TL, Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem. 2007;282:36275–36282. doi: 10.1074/jbc.M703561200.10.1074/jbc.M70356120017942401Carayannopoulos MO, Chi MM, Cui Y, Pingsterhaus JM, McKnight RA, Mueckler M, Devaskar SU, Moley KH. GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst. Proc Natl Acad Sci U S A. 2000;97:7313–7318. doi: 10.1073/pnas.97.13.7313.10.1073/pnas.97.13.7313PMC1654210860996Caruana BT, Byrne FL, Knights AJ, Quinlan KGR, Hoehn KL. Characterization of glucose transporter 6 in lipopolysaccharide-induced bone marrow-derived macrophage function. J Immunol. 2019;202:1826–1832. doi: 10.4049/jimmunol.1801063.10.4049/jimmunol.180106330700586Castro CN, Barcala Tabarrozzi AE, Winnewisser J, Gimeno ML, Antunica Noguerol M, Liberman AC, Paz DA, Dewey RA, Perone MJ. Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes. Clin Exp Immunol. 2014;177:149–160. doi: 10.1111/cei.12322.10.1111/cei.12322PMC408916424628444Chatton JY, Magistretti PJ, Barros LF. Sodium signaling and astrocyte energy metabolism. Glia. 2016;64:1667–1676. doi: 10.1002/glia.22971.10.1002/glia.2297127027636Chavez JC, LaManna JC. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci. 2002;22:8922–8931.PMC675770112388599Chen J, Williams S, Ho S, Loraine H, Hagan D, Whaley JM, Feder JN. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther. 2010;1:57–92. doi: 10.1007/s13300-010-0006-4.10.1007/s13300-010-0006-4PMC313848222127746Cheng CM, Cohen M, Wang J, Bondy CA. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J. 2001;15:907–915. doi: 10.1096/fj.00-0398com.10.1096/fj.00-0398com11292650Choeiri C, Staines W, Messier C. Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience. 2002;111:19–34. doi: 10.1016/s0306-4522(01)00619-4.10.1016/s0306-4522(01)00619-411955709Choeiri C, Staines W, Miki T, Seino S, Messier C. Glucose transporter plasticity during memory processing. Neuroscience. 2005;130:591–600. doi: 10.1016/j.neuroscience.2004.09.011.10.1016/j.neuroscience.2004.09.01115590143Choi TB, Boado RJ, Pardridge WM. Blood-brain barrier glucose transporter mRNA is increased in experimental diabetes mellitus. Biochem Biophys Res Commun. 1989;164:375–380. doi: 10.1016/0006-291x(89)91729-4.10.1016/0006-291x(89)91729-42803307Chuquet J, Quilichini P, Nimchinsky EA, Buzsaki G. Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex. J Neurosci. 2010;30:15298–15303. doi: 10.1523/JNEUROSCI.0762-10.2010.10.1523/JNEUROSCI.0762-10.2010PMC299726921068334Ciofi P. The arcuate nucleus as a circumventricular organ in the mouse. Neurosci Lett. 2011;487:187–190. doi: 10.1016/j.neulet.2010.10.019.10.1016/j.neulet.2010.10.01920951768Ciofi P, Garret M, Lapirot O, Lafon P, Loyens A, Prevot V, Levine JE. Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. Endocrinology. 2009;150:5509–5519. doi: 10.1210/en.2009-0584.10.1210/en.2009-0584PMC281974219837874Cisternas P, Silva-Alvarez C, Martinez F, Fernandez E, Ferrada L, Oyarce K, Salazar K, Bolanos JP, Nualart F. The oxidized form of vitamin C, dehydroascorbic acid, regulates neuronal energy metabolism. J Neurochem. 2014;129:663–671. doi: 10.1111/jnc.12663.10.1111/jnc.1266324460956Claret M, Smith MA, Batterham RL, Selman C, Choudhury AI, Fryer LG, Clements M, Al-Qassab H, Heffron H, Xu AW, Speakman JR, Barsh GS, Viollet B, Vaulont S, Ashford ML, Carling D, Withers DJ. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest. 2007;117:2325–2336. doi: 10.1172/JCI31516.10.1172/JCI31516PMC193457817671657Colville CA, Seatter MJ, Jess TJ, Gould GW, Thomas HM. Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors. Biochem J. 1993;290(Pt 3):701–706. doi: 10.1042/bj2900701.10.1042/bj2900701PMC11323378457197Cordner ZA, Tamashiro KL. Effects of high-fat diet exposure on learning & memory. Physiol Behav. 2015;152:363–371. doi: 10.1016/j.physbeh.2015.06.008.10.1016/j.physbeh.2015.06.008PMC572974526066731Cornford EM, Hyman S. Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx. 2005;2:27–43. doi: 10.1602/neurorx.2.1.27.10.1602/neurorx.2.1.27PMC53931815717055Cornford EM, Hyman S, Pardridge WM. An electron microscopic immunogold analysis of developmental up-regulation of the blood-brain barrier GLUT1 glucose transporter. J Cereb Blood Flow Metab. 1993;13:841–854. doi: 10.1038/jcbfm.1993.106.10.1038/jcbfm.1993.1068360290Cornford EM, Hyman S, Cornford ME, Caron MJ. Glut1 glucose transporter activity in human brain injury. J Neurotrauma. 1996;13:523–536. doi: 10.1089/neu.1996.13.523.10.1089/neu.1996.13.5238913969Cornford EM, Hyman S, Cornford ME, Damian RT, Raleigh MJ. A single glucose transporter configuration in normal primate brain endothelium: comparison with resected human brain. J Neuropathol Exp Neurol. 1998;57:699–713. doi: 10.1097/00005072-199807000-00007.10.1097/00005072-199807000-000079690674Cornford EM, Hyman S, Cornford ME, Landaw EM, Delgado-Escueta AV. Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier. J Cereb Blood Flow Metab. 1998;18:26–42. doi: 10.1097/00004647-199801000-00003.10.1097/00004647-199801000-000039428303Cornford EM, Nguyen EV, Landaw EM. Acute upregulation of blood-brain barrier glucose transporter activity in seizures. Am J Physiol Heart Circ Physiol. 2000;279:H1346–H1354. doi: 10.1152/ajpheart.2000.279.3.H1346.10.1152/ajpheart.2000.279.3.H134610993802Cruz J. An additional therapeutic effect of adequate hyperventilation in severe acute brain trauma: normalization of cerebral glucose uptake. J Neurosurg. 1995;82:379–385. doi: 10.3171/jns.1995.82.3.0379.10.3171/jns.1995.82.3.03797861214Csajbok EA, Tamas G. Cerebral cortex: a target and source of insulin? Diabetologia. 2016;59:1609–1615. doi: 10.1007/s00125-016-3996-2.10.1007/s00125-016-3996-227207082Cura AJ, Carruthers A. Acute modulation of sugar transport in brain capillary endothelial cell cultures during activation of the metabolic stress pathway. J Biol Chem. 2010;285:15430–15439. doi: 10.1074/jbc.M110.110593.10.1074/jbc.M110.110593PMC286529420231288Dakic T, Jevdjovic T, Lakic I, Djurasevic SF, Djordjevic J, Vujovic P. Food for thought: short-term fasting upregulates glucose transporters in neurons and endothelial cells, but not in astrocytes. Neurochem Res. 2019;44:388–399. doi: 10.1007/s11064-018-2685-6.10.1007/s11064-018-2685-630460639Dallaporta M, Himmi T, Perrin J, Orsini JC. Solitary tract nucleus sensitivity to moderate changes in glucose level. Neuroreport. 1999;10:2657–2660. doi: 10.1097/00001756-199908200-00040.10.1097/00001756-199908200-0004010574387Daulatzai MA. Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s disease. J Neurosci Res. 2017;95:943–972. doi: 10.1002/jnr.23777.10.1002/jnr.2377727350397De Giorgis V, Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure. 2013;22:803–811. doi: 10.1016/j.seizure.2013.07.003.10.1016/j.seizure.2013.07.00323890838de Groot TJ, Veyhl M, Terwinghe C, Vanden Bempt V, Dupont P, Mortelmans L, Verbruggen AM, Bormans GM, Koepsell H. Synthesis of 18F-fluoroalkyl-beta-D-glucosides and their evaluation as tracers for sodium-dependent glucose transporters. J Nucl Med. 2003;44:1973–1981.14660724De Salles AA, Muizelaar JP, Young HF. Hyperglycemia, cerebrospinal fluid lactic acidosis, and cerebral blood flow in severely head-injured patients. Neurosurgery. 1987;21:45–50.3614603De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, Tsui WH, Kandil E, Boppana M, Daisley K, Wang GJ, Schlyer D, Fowler J. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging. 2001;22:529–539. doi: 10.1016/s0197-4580(01)00230-5.10.1016/s0197-4580(01)00230-511445252De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991;325:703–709. doi: 10.1056/NEJM199109053251006.10.1056/NEJM1991090532510061714544Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003;9:907–913. doi: 10.1038/nm890.10.1038/nm89012808450DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol. 1990;27:457–464. doi: 10.1002/ana.410270502.10.1002/ana.4102705022360787Devraj K, Klinger ME, Myers RL, Mokashi A, Hawkins RA, Simpson IA. GLUT-1 glucose transporters in the blood-brain barrier: differential phosphorylation. J Neurosci Res. 2011;89:1913–1925. doi: 10.1002/jnr.22738.10.1002/jnr.22738PMC383574721910135Dick AP, Harik SI, Klip A, Walker DM. Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. Proc Natl Acad Sci U S A. 1984;81:7233–7237. doi: 10.1073/pnas.81.22.7233.10.1073/pnas.81.22.7233PMC3921136150484Dietrich WD, Alonso O, Busto R, Ginsberg MD. Widespread metabolic depression and reduced somatosensory circuit activation following traumatic brain injury in rats. J Neurotrauma. 1994;11:629–640. doi: 10.1089/neu.1994.11.629.10.1089/neu.1994.11.6297723063Diez-Sampedro A, Hirayama BA, Osswald C, Gorboulev V, Baumgarten K, Volk C, Wright EM, Koepsell H. A glucose sensor hiding in a family of transporters. PNAS. 2003;100:11753–11758.PMC20883013130073Diggs-Andrews KA, Zhang X, Song Z, Daphna-Iken D, Routh VH, Fisher SJ. Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia. Diabetes. 2010;59:2271–2280. doi: 10.2337/db10-0401.10.2337/db10-0401PMC292795020547974Ding JY, Kreipke CW, Schafer P, Schafer S, Speirs SL, Rafols JA. Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1alpha expression. Brain Res. 2009;1268:125–134. doi: 10.1016/j.brainres.2009.02.060.10.1016/j.brainres.2009.02.060PMC266873119285046Ding JY, Kreipke CW, Speirs SL, Schafer P, Schafer S, Rafols JA. Hypoxia-inducible factor-1alpha signaling in aquaporin upregulation after traumatic brain injury. Neurosci Lett. 2009;453:68–72. doi: 10.1016/j.neulet.2009.01.077.10.1016/j.neulet.2009.01.077PMC270342619429018Dixon CE, Lyeth BG, Povlishock JT, Findling RL, Hamm RJ, Marmarou A, Young HF, Hayes RL. A fluid percussion model of experimental brain injury in the rat. J Neurosurg. 1987;67:110–119. doi: 10.3171/jns.1987.67.1.0110.10.3171/jns.1987.67.1.01103598659Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL. A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods. 1991;39:253–262. doi: 10.1016/0165-0270(91)90104-8.10.1016/0165-0270(91)90104-81787745Dobrogowska DH, Vorbrodt AW. Quantitative immunocytochemical study of blood-brain barrier glucose transporter (GLUT-1) in four regions of mouse brain. J Histochem Cytochem. 1999;47:1021–1030. doi: 10.1177/002215549904700806.10.1177/00221554990470080610424886Doege H, Bocianski A, Joost HG, Schurmann A. Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J. 2000;350(Pt 3):771–776.PMC122130910970791Doege H, Schurmann A, Bahrenberg G, Brauers A, Joost HG. GLUT8, a novel member of the sugar transport facilitator family with glucose transport activity. J Biol Chem. 2000;275:16275–16280. doi: 10.1074/jbc.275.21.16275.10.1074/jbc.275.21.1627510821868Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI. Positron emission tomography in Alzheimer’s disease. Neurology. 1986;36:879–887. doi: 10.1212/wnl.36.7.879.10.1212/wnl.36.7.8793487046Duvernoy HM, Risold PY. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev. 2007;56:119–147.17659349Dwyer KJ, Pardridge WM. Developmental modulation of blood-brain barrier and choroid plexus GLUT1 glucose transporter messenger ribonucleic acid and immunoreactive protein in rabbits. Endocrinology. 1993;132:558–565. doi: 10.1210/endo.132.2.8093876.10.1210/endo.132.2.80938768093876El Messari S, Leloup C, Quignon M, Brisorgueil MJ, Penicaud L, Arluison M. Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system. J Comp Neurol. 1998;399:492–512.9741479El Messari S, Ait-Ikhlef A, Ambroise DH, Penicaud L, Arluison M. Expression of insulin-responsive glucose transporter GLUT4 mRNA in the rat brain and spinal cord: an in situ hybridization study. J Chem Neuroanat. 2002;24:225–242.12406499Elfeber K, Kohler A, Lutzenburg M, Osswald C, Galla HJ, Witte OW, Koepsell H. Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier. Histochem Cell Biol. 2004;121:201–207. doi: 10.1007/s00418-004-0633-9.10.1007/s00418-004-0633-914986005Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H, Wolf PA. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham study. Diabetes Care. 1997;20:1388–1395. doi: 10.2337/diacare.20.9.1388.10.2337/diacare.20.9.13889283785Emmanuel Y, Cochlin LE, Tyler DJ, de Jager CA, Smith AD, Clarke K. Human hippocampal energy metabolism is impaired during cognitive activity in a lipid infusion model of insulin resistance. Brain Behav. 2013;3:134–144. doi: 10.1002/brb3.124.10.1002/brb3.124PMC360715423533158Enerson BE, Drewes LR. The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab. 2006;26:959–973. doi: 10.1038/sj.jcbfm.9600249.10.1038/sj.jcbfm.960024916306934Eny KM, Wolever TM, Fontaine-Bisson B, El-Sohemy A. Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations. Physiol Genomics. 2008;33:355–360. doi: 10.1152/physiolgenomics.00148.2007.10.1152/physiolgenomics.00148.200718349384Eskelinen MH, Ngandu T, Helkala EL, Tuomilehto J, Nissinen A, Soininen H, Kivipelto M. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int J Geriatr Psychiatry. 2008;23:741–747. doi: 10.1002/gps.1969.10.1002/gps.196918188871Estus S, Golde TE, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu XM, Tabira T, Greenberg BD, et al. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science. 1992;255:726–728. doi: 10.1126/science.1738846.10.1126/science.17388461738846Fadel JR, Reagan LP. Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits. Curr Opin Behav Sci. 2016;9:47–54. doi: 10.1016/j.cobeha.2015.12.004.10.1016/j.cobeha.2015.12.004PMC477808526955646Fan X, Chan O, Ding Y, Zhu W, Mastaitis J, Sherwin R. Reduction in SGLT1 mRNA expression in the ventromedial hypothalamus improves the counterregulatory responses to hypoglycemia in recurrently hypoglycemic and diabetic rats. Diabetes. 2015;64:3564–3572. doi: 10.2337/db15-0022.10.2337/db15-0022PMC458764326130763Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS, Cryer PE, Powers WJ. Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes. 1998;47:1444–1450. doi: 10.2337/diabetes.47.9.1444.10.2337/diabetes.47.9.14449726233Farrell CL, Pardridge WM. Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci U S A. 1991;88:5779–5783.PMC519612062858Fawver JN, Schall HE, Petrofes Chapa RD, Zhu X, Murray IV. Amyloid-beta metabolite sensing: biochemical linking of glycation modification and misfolding. J Alzheimers Dis. 2012;30:63–73. doi: 10.3233/JAD-2012-112114.10.3233/JAD-2012-11211422406446Fernandez AM, Hernandez-Garzon E, Perez-Domper P, Perez-Alvarez A, Mederos S, Matsui T, Santi A, Trueba-Saiz A, Garcia-Guerra L, Pose-Utrilla J, Fielitz J, Olson EN, Fernandez de la Rosa R, Garcia Garcia L, Pozo MA, Iglesias T, Araque A, Soya H, Perea G, Martin ED, Torres Aleman I. Insulin regulates astrocytic glucose handling through cooperation with IGF-I. Diabetes. 2017;66:64–74. doi: 10.2337/db16-0861.10.2337/db16-086127999108Fioramonti X, Song Z, Vazirani RP, Beuve A, Routh VH. Hypothalamic nitric oxide in hypoglycemia detection and counterregulation: a two-edged sword. Antioxid Redox Signal. 2011;14:505–517. doi: 10.1089/ars.2010.3331.10.1089/ars.2010.3331PMC302517720518706Fischbarg J, Kuang KY, Vera JC, Arant S, Silverstein SC, Loike J, Rosen OM. Glucose transporters serve as water channels. Proc Natl Acad Sci U S A. 1990;87:3244–3247. doi: 10.1073/pnas.87.8.3244.10.1073/pnas.87.8.3244PMC538722326282Fischer VW, Siddiqi A, Yusufaly Y. Altered angioarchitecture in selected areas of brains with Alzheimer’s disease. Acta Neuropathol. 1990;79:672–679. doi: 10.1007/BF00294246.10.1007/BF002942462360411Fisher SJ, Bruning JC, Lannon S, Kahn CR. Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia. Diabetes. 2005;54:1447–1451. doi: 10.2337/diabetes.54.5.1447.10.2337/diabetes.54.5.144715855332Francis H, Stevenson R. The longer-term impacts of Western diet on human cognition and the brain. Appetite. 2013;63:119–128. doi: 10.1016/j.appet.2012.12.018.10.1016/j.appet.2012.12.01823291218Frayling C, Britton R, Dale N. ATP-mediated glucosensing by hypothalamic tanycytes. J Physiol. 2011;589:2275–2286. doi: 10.1113/jphysiol.2010.202051.10.1113/jphysiol.2010.202051PMC309870321486800Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF. Regional cerebral glucose transport and utilization in Alzheimer’s disease. Neurology. 1989;39:1427–1434. doi: 10.1212/wnl.39.11.1427.10.1212/wnl.39.11.14272812318Funari VA, Herrera VL, Freeman D, Tolan DR. Genes required for fructose metabolism are expressed in Purkinje cells in the cerebellum. Brain Res Mol Brain Res. 2005;142:115–122. doi: 10.1016/j.molbrainres.2005.09.019.10.1016/j.molbrainres.2005.09.01916266770Garcia MA, Carrasco M, Godoy A, Reinicke K, Montecinos VP, Aguayo LG, Tapia JC, Vera JC, Nualart F. Elevated expression of glucose transporter-1 in hypothalamic ependymal cells not involved in the formation of the brain-cerebrospinal fluid barrier. J Cell Biochem. 2001;80:491–503.11169733Garcia M, Millan C, Balmaceda-Aguilera C, Castro T, Pastor P, Montecinos H, Reinicke K, Zuniga F, Vera JC, Onate SA, Nualart F. Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem. 2003;86:709–724. doi: 10.1046/j.1471-4159.2003.01892.x.10.1046/j.1471-4159.2003.01892.x12859684Garcia-Caceres C, Quarta C, Varela L, Gao Y, Gruber T, Legutko B, Jastroch M, Johansson P, Ninkovic J, Yi CX, Le Thuc O, Szigeti-Buck K, Cai W, Meyer CW, Pfluger PT, Fernandez AM, Luquet S, Woods SC, Torres-Aleman I, Kahn CR, Gotz M, Horvath TL, Tschop MH. Astrocytic insulin signaling couples brain glucose uptake with nutrient availability. Cell. 2016;166:867–880. doi: 10.1016/j.cell.2016.07.028.10.1016/j.cell.2016.07.028PMC896144927518562Gerhart DZ, LeVasseur RJ, Broderius MA, Drewes LR. Glucose transporter localization in brain using light and electron immunocytochemistry. J Neurosci Res. 1989;22:464–472.2668543Gerhart DZ, Broderius MA, Borson ND, Drewes LR. Neurons and microvessels express the brain glucose transporter protein GLUT3. Proc Natl Acad Sci U S A. 1992;89:733–737. doi: 10.1073/pnas.89.2.733.10.1073/pnas.89.2.733PMC483131731347Gerhart DZ, Leino RL, Taylor WE, Borson ND, Drewes LR. GLUT1 and GLUT3 gene expression in gerbil brain following brief ischemia: an in situ hybridization study. Brain Res Mol Brain Res. 1994;25:313–322. doi: 10.1016/0169-328x(94)90167-8.10.1016/0169-328x(94)90167-87808230Gerhart DZ, Leino RL, Borson ND, Taylor WE, Gronlund KM, McCall AL, Drewes LR. Localization of glucose transporter GLUT 3 in brain: comparison of rodent and dog using species-specific carboxyl-terminal antisera. Neuroscience. 1995;66:237–246.7637872Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, Drewes LR. Expression of the monocarboxylate transporter MCT2 by rat brain glia. Glia. 1998;22:272–281.9482213Glick Z, Mayer J. Hyperphagia caused by cerebral ventricular infusion of phloridzin. Nature. 1968;219:1374. doi: 10.1038/2191374a0.10.1038/2191374a05245323Gold PE. Glucose and age-related changes in memory. Neurobiol Aging. 2005;26(Suppl 1):60–64. doi: 10.1016/j.neurobiolaging.2005.09.002.10.1016/j.neurobiolaging.2005.09.00216225962Goodman JC, Valadka AB, Gopinath SP, Uzura M, Robertson CS. Extracellular lactate and glucose alterations in the brain after head injury measured by microdialysis. Crit Care Med. 1999;27:1965–1973.10507626Gordon GR, Choi HB, Rungta RL, Ellis-Davies GC, MacVicar BA. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature. 2008;456:745–749. doi: 10.1038/nature07525.10.1038/nature07525PMC409702218971930Gould GW, Holman GD. The glucose transporter family: structure, function and tissue-specific expression. Biochem J. 1993;295:329–341.PMC11348868240230Gould GW, Thomas HM, Jess TJ, Bell GI. Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms. Biochemistry. 1991;30:5139–5145. doi: 10.1021/bi00235a004.10.1021/bi00235a0042036379Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016–1037. doi: 10.7326/0003-4819-117-12-1016.10.7326/0003-4819-117-12-10161443971Greenwood CE, Winocur G. Learning and memory impairment in rats fed a high saturated fat diet. Behav Neural Biol. 1990;53:74–87. doi: 10.1016/0163-1047(90)90831-p.10.1016/0163-1047(90)90831-p2302144Greenwood CE, Winocur G. Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake. Behav Neurosci. 1996;110:451–459. doi: 10.1037//0735-7044.110.3.451.10.1037//0735-7044.110.3.4518888990Greenwood CE, Winocur G. High-fat diets, insulin resistance and declining cognitive function. Neurobiol Aging. 2005;26(Suppl 1):42–45. doi: 10.1016/j.neurobiolaging.2005.08.017.10.1016/j.neurobiolaging.2005.08.01716257476Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, Cummings SR. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med. 2000;160:174–180. doi: 10.1001/archinte.160.2.174.10.1001/archinte.160.2.17410647755Grillo CA, Piroli GG, Hendry RM, Reagan LP. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res. 2009;1296:35–45. doi: 10.1016/j.brainres.2009.08.005.10.1016/j.brainres.2009.08.005PMC299752619679110Gu J, Jin N, Ma D, Chu D, Iqbal K, Gong CX, Liu F. Calpain I activation causes GLUT3 proteolysis and downregulation of O-GlcNAcylation in Alzheimer’s disease brain. J Alzheimers Dis. 2018;62:1737–1746. doi: 10.3233/JAD-171047.10.3233/JAD-17104729614685Guillemain G, Loizeau M, Pinçon-Raymond M, Girard J, Leturque A. The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells. J Cell Sci. 2000;113(Pt 5):841–847.10671373Guillod-Maximin E, Lorsignol A, Alquier T, Penicaud L. Acute intracarotid glucose injection towards the brain induces specific c-fos activation in hypothalamic nuclei: involvement of astrocytes in cerebral glucose-sensing in rats. J Neuroendocrinol. 2004;16:464–471. doi: 10.1111/j.1365-2826.2004.01185.x.10.1111/j.1365-2826.2004.01185.x15117340Gutniak M, Blomqvist G, Widen L, Stone-Elander S, Hamberger B, Grill V. D-[U-11C]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am J Phys. 1990;258:E805–E812. doi: 10.1152/ajpendo.1990.258.5.E805.10.1152/ajpendo.1990.258.5.E8052185663Hacker HJ, Thorens B, Grobholz R. Expression of facilitative glucose transporter in rat liver and choroid plexus. A histochemical study in native cryostat sections. Histochemistry. 1991;96:435–439. doi: 10.1007/bf00316001.10.1007/bf003160011748567Hall JL, Reilly RT, Cottrill KL, Stone WS, Gold PE. Phlorizin enhancement of memory in rats and mice. Pharmacol Biochem Behav. 1992;41:295–299. doi: 10.1016/0091-3057(92)90101-k.10.1016/0091-3057(92)90101-k1574518Hamlin GP, Cernak I, Wixey JA, Vink R. Increased expression of neuronal glucose transporter 3 but not glial glucose transporter 1 following severe diffuse traumatic brain injury in rats. J Neurotrauma. 2001;18:1011–1018. doi: 10.1089/08977150152693700.10.1089/0897715015269370011686488Harada S, Fujita WH, Shichi K, Tokuyama S. The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res. 2009;1279:174–181. doi: 10.1016/j.brainres.2009.05.014.10.1016/j.brainres.2009.05.01419445903Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992;256:184–185. doi: 10.1126/science.1566067.10.1126/science.15660671566067Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356. doi: 10.1126/science.1072994.10.1126/science.107299412130773Harr SD, Simonian NA, Hyman BT. Functional alterations in Alzheimer’s disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J Neuropathol Exp Neurol. 1995;54:38–41.7815078Harris JJ, Jolivet R, Attwell D. Synaptic energy use and supply. Neuron. 2012;75:762–777. doi: 10.1016/j.neuron.2012.08.019.10.1016/j.neuron.2012.08.01922958818Hashimoto N, Kagitani-Shimono K, Sakai N, Otomo T, Tominaga K, Nabatame S, Mogami Y, Takahashi Y, Imai K, Yanagihara K, Okinaga T, Nagai T, Taniike M, Ozono K. SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome. J Hum Genet. 2011;56:846–851. doi: 10.1038/jhg.2011.115.10.1038/jhg.2011.11522011817Hassel B, Elsais A, Froland AS, Tauboll E, Gjerstad L, Quan Y, Dingledine R, Rise F. Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitro. J Neurochem. 2015;133:572–581. doi: 10.1111/jnc.13079.10.1111/jnc.13079PMC442791125708447Hawkins RA, Peterson DR, Vina JR. The complementary membranes forming the blood-brain barrier. IUBMB Life. 2002;54:101–107. doi: 10.1080/15216540214541.10.1080/1521654021454112489636Heilig CW, Saunders T, Brosius FC, III, Moley K, Heilig K, Baggs R, Guo L, Conner D. Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy. Proc Natl Acad Sci U S A. 2003;100:15613–15618.PMC30761614673082Heiss WD, Szelies B, Kessler J, Herholz K. Abnormalities of energy metabolism in Alzheimer’s disease studied with PET. Ann N Y Acad Sci. 1991;640:65–71. doi: 10.1111/j.1749-6632.1991.tb00192.x.10.1111/j.1749-6632.1991.tb00192.x1776760Hellewell SC, Ziebell JM, Lifshitz J, Morganti-Kossmann MC. Impact acceleration model of diffuse traumatic brain injury. Methods Mol Biol. 2016;1462:253–266. doi: 10.1007/978-1-4939-3816-2_15.10.1007/978-1-4939-3816-2_1527604723Heneka MT, Nicotera P. Thoughts on obesity and brain glucose. Cell. 2016;165:773–775. doi: 10.1016/j.cell.2016.04.057.10.1016/j.cell.2016.04.05727153489Holmes CS. Neuropsychological profiles in men with insulin-dependent diabetes. J Consult Clin Psychol. 1986;54:386–389. doi: 10.1037//0022-006x.54.3.386.10.1037//0022-006x.54.3.3863722568Hooijmans CR, Graven C, Dederen PJ, Tanila H, van Groen T, Kiliaan AJ. Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res. 2007;1181:93–103. doi: 10.1016/j.brainres.2007.08.063.10.1016/j.brainres.2007.08.06317916337Horwood N, Davies DC. Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer’s disease. Virchows Arch. 1994;425:69–72. doi: 10.1007/bf00193951.10.1007/bf001939517921416Hu Y, Wilson GS. A temporary local energy pool coupled to neuronal activity: fluctuations of extracellular lactate levels in rat brain monitored with rapid-response enzyme-based sensor. J Neurochem. 1997;69:1484–1490. doi: 10.1046/j.1471-4159.1997.69041484.x.10.1046/j.1471-4159.1997.69041484.x9326277Huang S, Czech MP. The GLUT4 glucose transporter. Cell Metab. 2007;5:237–252. doi: 10.1016/j.cmet.2007.03.006.10.1016/j.cmet.2007.03.00617403369Huang RQ, Cheng HL, Zhao XD, Dai W, Zhuang Z, Wu Y, Liu Y, Shi JX. Preliminary study on the effect of trauma-induced secondary cellular hypoxia in brain injury. Neurosci Lett. 2010;473:22–27. doi: 10.1016/j.neulet.2010.02.011.10.1016/j.neulet.2010.02.01120152885Hyder F, Patel AB, Gjedde A, Rothman DL, Behar KL, Shulman RG. Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab. 2006;26:865–877. doi: 10.1038/sj.jcbfm.9600263.10.1038/sj.jcbfm.960026316407855Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci. 2004;5:347–360. doi: 10.1038/nrn1387.10.1038/nrn138715100718Ibberson M, Uldry M, Thorens B. GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues. J Biol Chem. 2000;275:4607–4612. doi: 10.1074/jbc.275.7.4607.10.1074/jbc.275.7.460710671487Ibberson M, Riederer BM, Uldry M, Guhl B, Roth J, Thorens B. Immunolocalization of GLUTX1 in the testis and to specific brain areas and vasopressin-containing neurons. Endocrinology. 2002;143:276–284. doi: 10.1210/endo.143.1.8587.10.1210/endo.143.1.858711751619Ibrahim N, Bosch MA, Smart JL, Qiu J, Rubinstein M, Ronnekleiv OK, Low MJ, Kelly MJ. Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology. 2003;144:1331–1340. doi: 10.1210/en.2002-221033.10.1210/en.2002-22103312639916Irani BG, Le Foll C, Dunn-Meynell A, Levin BE. Effects of leptin on rat ventromedial hypothalamic neurons. Endocrinology. 2008;149:5146–5154. doi: 10.1210/en.2008-0357.10.1210/en.2008-0357PMC258292418556346Iserovich P, Wang D, Ma L, Yang H, Zuniga FA, Pascual JM, Kuang K, De Vivo DC, Fischbarg J. Changes in glucose transport and water permeability resulting from the T310I pathogenic mutation in Glut1 are consistent with two transport channels per monomer. J Biol Chem. 2002;277:30991–30997. doi: 10.1074/jbc.M202763200.10.1074/jbc.M20276320012032147Ishida N, Saito M, Sato S, Koepsell H, Taira E, Hirose M. SGLT1 participates in the development of vascular cognitive impairment in a mouse model of small vessel disease. Neurosci Lett. 2020;727:134929. doi: 10.1016/j.neulet.2020.134929.10.1016/j.neulet.2020.13492932217089Ito Y, Oguni H, Ito S, Oguni M, Osawa M. A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol. 2011;53:658–663. doi: 10.1111/j.1469-8749.2011.03961.x.10.1111/j.1469-8749.2011.03961.x21501156Iwabuchi S, Kawahara K. Inducible astrocytic glucose transporter-3 contributes to the enhanced storage of intracellular glycogen during reperfusion after ischemia. Neurochem Int. 2011;59:319–325. doi: 10.1016/j.neuint.2011.06.006.10.1016/j.neuint.2011.06.00621703319Iwata N, Okazaki M, Xuan M, Kamiuchi S, Matsuzaki H, Hibino Y. Orally administrated ascorbic acid suppresses neuronal damage and modifies expression of SVCT2 and GLUT1 in the brain of diabetic rats with cerebral ischemia-reperfusion. Nutrients. 2014;6:1554–1577. doi: 10.3390/nu6041554.10.3390/nu6041554PMC401105124739976Jacobsen KT, Iverfeldt K. O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-beta precursor protein (APP) Biochem Biophys Res Commun. 2011;404:882–886. doi: 10.1016/j.bbrc.2010.12.080.10.1016/j.bbrc.2010.12.08021182826Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, Coxson PG, Budinger TF. Diminished glucose transport in Alzheimer’s disease: dynamic PET studies. J Cereb Blood Flow Metab. 1991;11:323–330. doi: 10.1038/jcbfm.1991.65.10.1038/jcbfm.1991.651997504Jagust WJ, Haan MN, Eberling JL, Wolfe N, Reed BR. Functional imaging predicts cognitive decline in Alzheimer’s disease. J Neuroimaging. 1996;6:156–160. doi: 10.1111/jon199663156.10.1111/jon1996631568704290Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Forster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Bruning JC. Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity. Cell. 2016;165:882–895. doi: 10.1016/j.cell.2016.03.033.10.1016/j.cell.2016.03.03327133169Jarvis CR, Andrew RD. Correlated electrophysiology and morphology of the ependyma in rat hypothalamus. J Neurosci. 1988;8:3691–3702.PMC65696013193176Jiang X, McDermott JR, Ajees AA, Rosen BP, Liu Z. Trivalent arsenicals and glucose use different translocation pathways in mammalian GLUT1. Metallomics. 2010;2:211–219. doi: 10.1039/b920471g.10.1039/b920471gPMC373333021069159Johnson JH, Newgard CB, Milburn JL, Lodish HF, Thorens B. The high Km glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. J Biol Chem. 1990;265:6548–6551.2182619Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review) Mol Membr Biol. 2001;18:247–256.11780753Kacem K, Lacombe P, Seylaz J, Bonvento G. Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: a confocal microscopy study. Glia. 1998;23:1–10.9562180Kainulainen H, Schurmann A, Vilja P, Joost HG. In-vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT3 in brain tissue from streptozotocin-diabetic rats. Acta Physiol Scand. 1993;149:221–225. doi: 10.1111/j.1748-1716.1993.tb09615.x.10.1111/j.1748-1716.1993.tb09615.x8266811Kalaria RN, Harik SI. Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer’s disease. Prog Clin Biol Res. 1989;317:415–421.2602426Kane S, Seatter MJ, Gould GW. Functional studies of human GLUT5: effect of pH on substrate selection and an analysis of substrate interactions. Biochem Biophys Res Commun. 1997;238:503–505. doi: 10.1006/bbrc.1997.7204.10.1006/bbrc.1997.72049299540Kang L, Routh VH, Kuzhikandathil EV, Gaspers LD, Levin BE. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes. 2004;53:549–559. doi: 10.2337/diabetes.53.3.549.10.2337/diabetes.53.3.54914988237Kanoski SE, Davidson TL. Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol Behav. 2011;103:59–68. doi: 10.1016/j.physbeh.2010.12.003.10.1016/j.physbeh.2010.12.003PMC305691221167850Kasahara M, Hinkle PC. Reconstitution and purification of the D-glucose transporter from human erythrocytes. J Biol Chem. 1977;252:7384–7390.903365Kawamata T, Katayama Y, Hovda DA, Yoshino A, Becker DP. Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury. J Cereb Blood Flow Metab. 1992;12:12–24. doi: 10.1038/jcbfm.1992.3.10.1038/jcbfm.1992.31345756Kayano T, Burant CF, Fukumoto H, Gould GW, Fan YS, Eddy RL, Byers MG, Shows TB, Seino S, Bell GI. Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6) J Biol Chem. 1990;265:13276–13282.1695905Kc S, Carcamo JM, Golde DW. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J. 2005;19:1657–1667. doi: 10.1096/fj.05-4107com.10.1096/fj.05-4107com16195374Kim C, Nam DW, Park SY, Song H, Hong HS, Boo JH, Jung ES, Kim Y, Baek JY, Kim KS, Cho JW, Mook-Jung I. O-linked beta-N-acetylglucosaminidase inhibitor attenuates beta-amyloid plaque and rescues memory impairment. Neurobiol Aging. 2013;34:275–285. doi: 10.1016/j.neurobiolaging.2012.03.001.10.1016/j.neurobiolaging.2012.03.00122503002Klepper J, Leiendecker B, Bredahl R, Athanassopoulos S, Heinen F, Gertsen E, Florcken A, Metz A, Voit T. Introduction of a ketogenic diet in young infants. J Inherit Metab Dis. 2002;25:449–460. doi: 10.1023/a:1021238900470.10.1023/a:102123890047012555938Klepper J, Scheffer H, Leiendecker B, Gertsen E, Binder S, Leferink M, Hertzberg C, Nake A, Voit T, Willemsen MA. Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively. Neuropediatrics. 2005;36:302–308. doi: 10.1055/s-2005-872843.10.1055/s-2005-87284316217704Klepper J, Scheffer H, Elsaid MF, Kamsteeg EJ, Leferink M, Ben-Omran T. Autosomal recessive inheritance of GLUT1 deficiency syndrome. Neuropediatrics. 2009;40:207–210. doi: 10.1055/s-0030-1248264.10.1055/s-0030-124826420221955Kobayashi M, Nikami H, Morimatsu M, Saito M. Expression and localization of insulin-regulatable glucose transporter (GLUT4) in rat brain. Neurosci Lett. 1996;213:103–106.8858619Koepsell H. The Na(+)-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer. Pharmacol Ther. 2017;170:148–165. doi: 10.1016/j.pharmthera.2016.10.017.10.1016/j.pharmthera.2016.10.01727773781Koike MA, Green KN, Blurton-Jones M, Laferla FM. Oligemic hypoperfusion differentially affects tau and amyloid-{beta} Am J Pathol. 2010;177:300–310. doi: 10.2353/ajpath.2010.090750.10.2353/ajpath.2010.090750PMC289367320472896Kojo A, Yamada K, Yamamoto T. Glucose transporter 5 (GLUT5)-like immunoreactivity is localized in subsets of neurons and glia in the rat brain. J Chem Neuroanat. 2016;74:55–70. doi: 10.1016/j.jchemneu.2016.03.004.10.1016/j.jchemneu.2016.03.00427036089Komori T, Morikawa Y, Tamura S, Doi A, Nanjo K, Senba E. Subcellular localization of glucose transporter 4 in the hypothalamic arcuate nucleus of ob/ob mice under basal conditions. Brain Res. 2005;1049:34–42. doi: 10.1016/j.brainres.2005.04.079.10.1016/j.brainres.2005.04.07915925330Kong D, Vong L, Parton LE, Ye C, Tong Q, Hu X, Choi B, Bruning JC, Lowell BB. Glucose stimulation of hypothalamic MCH neurons involves K(ATP) channels, is modulated by UCP2, and regulates peripheral glucose homeostasis. Cell Metab. 2010;12:545–552. doi: 10.1016/j.cmet.2010.09.013.10.1016/j.cmet.2010.09.013PMC299819121035764Kovacs P, Hajnal A. In vivo electrophysiological effects of insulin in the rat brain. Neuropeptides. 2009;43:283–293. doi: 10.1016/j.npep.2009.05.006.10.1016/j.npep.2009.05.006PMC275977519541365Ksiezak-Reding H, Liu WK, Yen SH. Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res. 1992;597:209–219. doi: 10.1016/0006-8993(92)91476-u.10.1016/0006-8993(92)91476-u1472994Kubo Y, Ohtsuki S, Uchida Y, Terasaki T. Quantitative determination of luminal and abluminal membrane distributions of transporters in porcine brain capillaries by plasma membrane fractionation and quantitative targeted proteomics. J Pharm Sci. 2015;104:3060–3068. doi: 10.1002/jps.24398.10.1002/jps.2439825703048Kumagai AK, Dwyer KJ, Pardridge WM. Differential glycosylation of the GLUT1 glucose transporter in brain capillaries and choroid plexus. Biochim Biophys Acta. 1994;1193:24–30.8038191Kurita H, Xu KY, Maejima Y, Nakata M, Dezaki K, Santoso P, Yang Y, Arai T, Gantulga D, Muroya S, Lefor AK, Kakei M, Watanabe E, Yada T. Arcuate Na+,K+-ATPase senses systemic energy states and regulates feeding behavior through glucose-inhibited neurons. Am J Physiol Endocrinol Metab. 2015;309:E320–E333. doi: 10.1152/ajpendo.00446.2014.10.1152/ajpendo.00446.201426081283Kuwabara T, Kagalwala MN, Onuma Y, Ito Y, Warashina M, Terashima K, Sanosaka T, Nakashima K, Gage FH, Asashima M. Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. EMBO Mol Med. 2011;3:742–754. doi: 10.1002/emmm.201100177.10.1002/emmm.201100177PMC337711821984534Lam AM, Winn HR, Cullen BF, Sundling N. Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg. 1991;75:545–551. doi: 10.3171/jns.1991.75.4.0545.10.3171/jns.1991.75.4.05451885972Lamy CM, Sanno H, Labouebe G, Picard A, Magnan C, Chatton JY, Thorens B. Hypoglycemia-activated GLUT2 neurons of the nucleus tractus solitarius stimulate vagal activity and glucagon secretion. Cell Metab. 2014;19:527–538. doi: 10.1016/j.cmet.2014.02.003.10.1016/j.cmet.2014.02.00324606905Lee WH, Bondy CA. Ischemic injury induces brain glucose transporter gene expression. Endocrinology. 1993;133:2540–2544. doi: 10.1210/endo.133.6.8243275.10.1210/endo.133.6.82432758243275Lee W-J, Peterson DR, Sukowski EJ, Hawkins RA. Glucose transport by isolated plasma membranes of the bovine blood-brain barrier. Am J Phys. 1997;272:C1552–C1557.9176146Leen WG, Klepper J, Verbeek MM, Leferink M, Hofste T, van Engelen BG, Wevers RA, Arthur T, Bahi-Buisson N, Ballhausen D, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain. 2010;133:655–670. doi: 10.1093/brain/awp336.10.1093/brain/awp33620129935Leen WG, Wevers RA, Kamsteeg EJ, Scheffer H, Verbeek MM, Willemsen MA. Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review. JAMA Neurol. 2013;70:1440–1444. doi: 10.1001/jamaneurol.2013.3090.10.1001/jamaneurol.2013.309023999624Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2007;445:168–176.17151600Leino RL, Gerhart DZ, van Bueren AM, McCall AL, Drewes LR. Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain. J Neurosci Res. 1997;49:617–626. doi: 10.1002/(SICI)1097-4547(19970901)49:5<617::AID-JNR12>3.0.CO;2-S.10.1002/(SICI)1097-4547(19970901)49:5<617::AID-JNR12>3.0.CO;2-S9302083Leino RL, Gerhart DZ, Drewes LR. Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Brain Res Dev Brain Res. 1999;113:47–54. doi: 10.1016/s0165-3806(98)00188-6.10.1016/s0165-3806(98)00188-610064873Leloup C, Arluison M, Lepetit N, Cartier N, Marfaing-Jallat P, Ferre P, Penicaud L. Glucose transporter 2 (GLUT 2): expression in specific brain nuclei. Brain Res. 1994;638:221–226. doi: 10.1016/0006-8993(94)90653-x.10.1016/0006-8993(94)90653-x8199863Leloup C, Arluison M, Kassis N, Lepetit N, Cartier N, Ferre P, Penicaud L. Discrete brain areas express the insulin-responsive glucose transporter GLUT4. Brain Res Mol Brain Res. 1996;38:45–53.8737666Leloup C, Orosco M, Serradas P, Nicolaidis S, Penicaud L. Specific inhibition of GLUT2 in arcuate nucleus by antisense oligonucleotides suppresses nervous control of insulin secretion. Brain Res Mol Brain Res. 1998;57:275–280. doi: 10.1016/s0169-328x(98)00097-7.10.1016/s0169-328x(98)00097-79675426Lisinski I, Schurmann A, Joost HG, Cushman SW, Al-Hasani H. Targeting of GLUT6 (formerly GLUT9) and GLUT8 in rat adipose cells. Biochem J. 2001;358:517–522. doi: 10.1042/0264-6021:3580517.10.1042/0264-6021:3580517PMC122208711513753Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2004;101:10804–10809. doi: 10.1073/pnas.0400348101.10.1073/pnas.0400348101PMC49001515249677Liu Z, Sanchez MA, Jiang X, Boles E, Landfear SM, Rosen BP. Mammalian glucose permease GLUT1 facilitates transport of arsenic trioxide and methylarsonous acid. Biochem Biophys Res Commun. 2006;351:424–430. doi: 10.1016/j.bbrc.2006.10.054.10.1016/j.bbrc.2006.10.054PMC176462117064664Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett. 2008;582:359–364. doi: 10.1016/j.febslet.2007.12.035.10.1016/j.febslet.2007.12.035PMC224736418174027Liu S, Levine SR, Winn HR. Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med. 2010;3:47–55. doi: 10.6030/1939-067x-3.1.47.10.6030/1939-067x-3.1.47PMC289600220607107Liu YC, Lee JW, Bellows ST, Damiano JA, Mullen SA, Berkovic SF, Bahlo M, Scheffer IE, Hildebrand MS, Clinical G. Evaluation of non-coding variation in GLUT1 deficiency. Dev Med Child Neurol. 2016;58:1295–1302. doi: 10.1111/dmcn.13163.10.1111/dmcn.1316327265003Loaiza A, Porras OH, Barros LF. Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci. 2003;23:7337–7342.PMC674043312917367Lopez-Gambero AJ, Martinez F, Salazar K, Cifuentes M, Nualart F. Brain glucose-sensing mechanism and energy homeostasis. Mol Neurobiol. 2019;56:769–796. doi: 10.1007/s12035-018-1099-4.10.1007/s12035-018-1099-429796992Lutz AJ, Pardridge WM. Insulin therapy normalizes GLUT1 glucose transporter mRNA but not immunoreactive transporter protein in streptozocin-diabetic rats. Metabolism. 1993;42:939–944.8345816Lyros E, Bakogiannis C, Liu Y, Fassbender K. Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer’s disease. Curr Alzheimer Res. 2014;11:18–26. doi: 10.2174/1567205010666131119235254.10.2174/156720501066613111923525424251393Mackenzie B, Panayotova-Heiermann M, Loo DD, Lever JE, Wright EM. SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation. J Biol Chem. 1994;269:22488–22491.8077195Maedera S, Mizuno T, Ishiguro H, Ito T, Soga T, Kusuhara H. GLUT6 is a lysosomal transporter that is regulated by inflammatory stimuli and modulates glycolysis in macrophages. FEBS Lett. 2019;593:195–208. doi: 10.1002/1873-3468.13298.10.1002/1873-3468.1329830431159Maekawa F, Toyoda Y, Torii N, Miwa I, Thompson RC, Foster DL, Tsukahara S, Tsukamura H, Maeda K-I. Localization of glucokinase-like immunoreactivity in the rat lower brain stem: for possible location of brain glucose-sensing mechanisms. Endocrinology. 2000;141:375–384.10614660Maher F, Simpson IA. The GLUT3 glucose transporter is the predominant isoform in primary cultured neurons: assessment by biosynthetic and photoaffinity labelling. Biochem J. 1994;301(Pt 2):379–384. doi: 10.1042/bj3010379.10.1042/bj3010379PMC11370918042980Maher F, Vannucci SJ, Simpson IA. Glucose transporter proteins in brain. FASEB J. 1994;8:1003–1011. doi: 10.1096/fasebj.8.13.7926364.10.1096/fasebj.8.13.79263647926364Maher F, Davies-Hill TM, Simpson IA. Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons. Biochem J. 1996;315(Pt 3):827–831. doi: 10.1042/bj3150827.10.1042/bj3150827PMC12172818645164Mancardi GL, Perdelli F, Rivano C, Leonardi A, Bugiani O. Thickening of the basement membrane of cortical capillaries in Alzheimer’s disease. Acta Neuropathol. 1980;49:79–83. doi: 10.1007/BF00692225.10.1007/BF006922257355675Mangia S, Giove F, Tkac I, Logothetis NK, Henry PG, Olman CA, Maraviglia B, Di Salle F, Ugurbil K. Metabolic and hemodynamic events after changes in neuronal activity: current hypotheses, theoretical predictions and in vivo NMR experimental findings. J Cereb Blood Flow Metab. 2009;29:441–463. doi: 10.1038/jcbfm.2008.134.10.1038/jcbfm.2008.134PMC274344319002199Mangia S, Simpson IA, Vannucci SJ, Carruthers A. The in vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation. J Neurochem. 2009;109(Suppl 1):55–62. doi: 10.1111/j.1471-4159.2009.06003.x.10.1111/j.1471-4159.2009.06003.xPMC267917919393009Mantych GJ, James DE, Chung HD, Devaskar SU. Cellular localization and characterization of Glut 3 glucose transporter isoform in human brain. Endocrinology. 1992;131:1270–1278. doi: 10.1210/endo.131.3.1505464.10.1210/endo.131.3.15054641505464Mantych GJ, James DE, Devaskar SU. Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier. Endocrinology. 1993;132:35–40. doi: 10.1210/endo.132.1.8419132.10.1210/endo.132.1.84191328419132Marchesi VT. Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J. 2011;25:5–13. doi: 10.1096/fj.11-0102ufm.10.1096/fj.11-0102ufm21205781Margolskee RF, Dyer J, Kokrashvili Z, Salmon KS, Ilegems E, Daly K, Maillet EL, Ninomiya Y, Mosinger B, Shirazi-Beechey SP. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc Natl Acad Sci U S A. 2007;104:15075–15080. doi: 10.1073/pnas.0706678104.10.1073/pnas.0706678104PMC198661517724332Marin-Juez R, Rovira M, Crespo D, van der Vaart M, Spaink HP, Planas JV. GLUT2-mediated glucose uptake and availability are required for embryonic brain development in zebrafish. J Cereb Blood Flow Metab. 2015;35:74–85. doi: 10.1038/jcbfm.2014.171.10.1038/jcbfm.2014.171PMC429439725294126Marin-Valencia I, Good LB, Ma Q, Duarte J, Bottiglieri T, Sinton CM, Heilig CW, Pascual JM. Glut1 deficiency (G1D): epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype. Neurobiol Dis. 2012;48:92–101. doi: 10.1016/j.nbd.2012.04.011.10.1016/j.nbd.2012.04.011PMC349516522683290Martinez F, Cifuentes M, Tapia JC, Nualart F. The median eminence as the hypothalamic area involved in rapid transfer of glucose to the brain: functional and cellular mechanisms. J Mol Med (Berl) 2019;97:1085–1097. doi: 10.1007/s00109-019-01799-5.10.1007/s00109-019-01799-531129757Marty N, Dallaporta M, Foretz M, Emery M, Tarussio D, Bady I, Binnert C, Beermann F, Thorens B. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors. J Clin Invest. 2005;115:3545–3553. doi: 10.1172/JCI26309.10.1172/JCI26309PMC129725616322792Martyn JA, Kaneki M, Yasuhara S. Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology. 2008;109:137–148. doi: 10.1097/ALN.0b013e3181799d45.10.1097/ALN.0b013e3181799d45PMC389697118580184Matz K, Keresztes K, Tatschl C, Nowotny M, Dachenhausen A, Brainin M, Tuomilehto J. Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes Care. 2006;29:792–797. doi: 10.2337/diacare.29.04.06.dc05-1818.10.2337/diacare.29.04.06.dc05-181816567817Mayer AL, Higgins CB, Heitmeier MR, Kraft TE, Qian X, Crowley JR, Hyrc KL, Beatty WL, Yarasheski KE, Hruz PW, DeBosch BJ. SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy. Sci Rep. 2016;6:38586. doi: 10.1038/srep38586.10.1038/srep38586PMC513864027922102McCall AL, Van Bueren AM, Moholt-Siebert M, Cherry NJ, Woodward WR. Immunohistochemical localization of the neuron-specific glucose transporter (GLUT3) to neuropil in adult rat brain. Brain Res. 1994;659:292–297.7820678McCall AL, Moholt-Siebert M, VanBueren A, Cherry NJ, Lessov N, Tiffany N, Thompson M, Downes H, Woodward WR. Progressive hippocampal loss of immunoreactive GLUT3, the neuron-specific glucose transporter, after global forebrain ischemia in the rat. Brain Res. 1995;670:29–38.7719721McCall AL, Van Bueren AM, Nipper V, Moholt-Siebert M, Downes H, Lessov N. Forebrain ischemia increases GLUT1 protein in brain microvessels and parenchyma. J Cereb Blood Flow Metab. 1996;16:69–76. doi: 10.1097/00004647-199601000-00008.10.1097/00004647-199601000-000088530557McCall AL, van Bueren AM, Huang L, Stenbit A, Celnik E, Charron MJ. Forebrain endothelium expresses GLUT4, the insulin-responsive glucose transporter. Brain Res. 1997;744:318–326. doi: 10.1016/S0006-8993(96)01122-5.10.1016/S0006-8993(96)01122-59027391McNay EC, Gold PE. Age-related differences in hippocampal extracellular fluid glucose concentration during behavioral testing and following systemic glucose administration. J Gerontol A Biol Sci Med Sci. 2001;56:B66–B71. doi: 10.1093/gerona/56.2.b66.10.1093/gerona/56.2.b6611213269McNay EC, Recknagel AK. Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes. Neurobiol Learn Mem. 2011;96:432–442. doi: 10.1016/j.nlm.2011.08.005.10.1016/j.nlm.2011.08.005PMC319006321907815McNay EC, Fries TM, Gold PE. Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proc Natl Acad Sci U S A. 2000;97:2881–2885. doi: 10.1073/pnas.050583697.10.1073/pnas.050583697PMC1602410706633McNay EC, McCarty RC, Gold PE. Fluctuations in brain glucose concentration during behavioral testing: dissociations between brain areas and between brain and blood. Neurobiol Learn Mem. 2001;75:325–337. doi: 10.1006/nlme.2000.3976.10.1006/nlme.2000.397611300738McNay EC, Ong CT, McCrimmon RJ, Cresswell J, Bogan JS, Sherwin RS. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem. 2010;93:546–553. doi: 10.1016/j.nlm.2010.02.002.10.1016/j.nlm.2010.02.002PMC287820720176121Melnick IV, Price CJ, Colmers WF. Glucosensing in parvocellular neurons of the rat hypothalamic paraventricular nucleus. Eur J Neurosci. 2011;34:272–282. doi: 10.1111/j.1460-9568.2011.07742.x.10.1111/j.1460-9568.2011.07742.x21692881Membrez M, Hummler E, Beermann F, Haefliger JA, Savioz R, Pedrazzini T, Thorens B. GLUT8 is dispensable for embryonic development but influences hippocampal neurogenesis and heart function. Mol Cell Biol. 2006;26:4268–4276. doi: 10.1128/MCB.00081-06.10.1128/MCB.00081-06PMC148910816705176Meneilly GS, Tessier DM. Diabetes, dementia and hypoglycemia. Can J Diabetes. 2016;40:73–76. doi: 10.1016/j.jcjd.2015.09.006.10.1016/j.jcjd.2015.09.00626778684Meuter F, Thomas W, Gruneklee D, Gries FA, Lohmann R. Psychometric evaluation of performance in diabetes mellitus. Horm Metab Res Suppl. 1980;9:9–17.6991384Mielke JG, Taghibiglou C, Liu L, Zhang Y, Jia Z, Adeli K, Wang YT. A biochemical and functional characterization of diet-induced brain insulin resistance. J Neurochem. 2005;93:1568–1578. doi: 10.1111/j.1471-4159.2005.03155.x.10.1111/j.1471-4159.2005.03155.x15935073Miki T, Liss B, Minami K, Shiuchi T, Saraya A, Kashima Y, Horiuchi M, Ashcroft F, Minokoshi Y, Roeper J, Seino S. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci. 2001;4:507–512. doi: 10.1038/87455.10.1038/8745511319559Mink JW, Blumenschine RJ, Adams DB. Ratio of central nervous system to body metabolism in vertebrates: its constancy and functional basis. Am J Phys. 1981;241:R203–R212. doi: 10.1152/ajpregu.1981.241.3.R203.10.1152/ajpregu.1981.241.3.R2037282965Miselis RR, Epstein AN. Feeding induced by intracerebroventricular 2-deoxy-D-glucose in the rat. Am J Phys. 1975;229:1438–1447. doi: 10.1152/ajplegacy.1975.229.5.1438.10.1152/ajplegacy.1975.229.5.14381200165Mooradian AD, Morin AM. Brain uptake of glucose in diabetes mellitus: the role of glucose transporters. Am J Med Sci. 1991;301:173–177. doi: 10.1097/00000441-199103000-00004.10.1097/00000441-199103000-000042000888Mooradian AD, Chung HC, Shah GN. GLUT-1 expression in the cerebra of patients with Alzheimer’s disease. Neurobiol Aging. 1997;18:469–474. doi: 10.1016/s0197-4580(97)00111-5.10.1016/s0197-4580(97)00111-59390772Morgello S, Uson RR, Schwartz EJ, Haber RS. The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. GLIA. 1995;14:43–54.7615345Moroo I, Yamada T. Immunohistochemistry using antibody to the glucose transporter 3 in human brainstem and cerebellar tissues. No To Shinkei. 1994;46:1039–1043.7873276Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology. 2004;62:1573–1579. doi: 10.1212/01.wnl.0000123250.82849.b6.10.1212/01.wnl.0000123250.82849.b615136684Morris GP, Clark IA, Vissel B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer’s disease. Acta Neuropathol Commun. 2014;2:135. doi: 10.1186/s40478-014-0135-5.10.1186/s40478-014-0135-5PMC420735425231068Mountjoy PD, Bailey SJ, Rutter GA. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia. 2007;50:168–177. doi: 10.1007/s00125-006-0473-3.10.1007/s00125-006-0473-317093945Mullier A, Bouret SG, Prevot V, Dehouck B. Differential distribution of tight junction proteins suggests a role for tanycytes in blood-hypothalamus barrier regulation in the adult mouse brain. J Comp Neurol. 2010;518:943–962. doi: 10.1002/cne.22273.10.1002/cne.22273PMC289251820127760Murakami R, Chiba Y, Tsuboi K, Matsumoto K, Kawauchi M, Fujihara R, Mashima M, Kanenishi K, Yamamoto T, Ueno M. Immunoreactivity of glucose transporter 8 is localized in the epithelial cells of the choroid plexus and in ependymal cells. Histochem Cell Biol. 2016;146:231–236. doi: 10.1007/s00418-016-1444-5.10.1007/s00418-016-1444-527160096Murray AJ, Knight NS, Cochlin LE, McAleese S, Deacon RM, Rawlins JN, Clarke K. Deterioration of physical performance and cognitive function in rats with short-term high-fat feeding. FASEB J. 2009;23:4353–4360. doi: 10.1096/fj.09-139691.10.1096/fj.09-13969119667117Nagai K, Inoue T, Konishi H. Increased gene expression of glucose transporters in the mouse brain after treatment with fluoxetine and pergolide. Drug Res (Stuttg) 2014;64:389–391. doi: 10.1055/s-0033-1358705.10.1055/s-0033-135870524227476Nagamatsu S, Sawa H, Kamada K, Nakamichi Y, Yoshimoto K, Hoshino T. Neuron-specific glucose transporter (NSGT): CNS distribution of GLUT3 rat glucose transporter (RGT3) in rat central neurons. FEBS Lett. 1993;334:289–295.8243635Narita H, Tanji K, Miki Y, Mori F, Wakabayashi K. Trehalose intake and exercise upregulate a glucose transporter, GLUT8, in the brain. Biochem Biophys Res Commun. 2019;514:672–677. doi: 10.1016/j.bbrc.2019.05.017.10.1016/j.bbrc.2019.05.01731078265Newman LA, Korol DL, Gold PE. Lactate produced by glycogenolysis in astrocytes regulates memory processing. PLoS One. 2011;6:e28427. doi: 10.1371/journal.pone.0028427.10.1371/journal.pone.0028427PMC323674822180782Ngarmukos C, Baur EL, Kumagai AK. Co-localization of GLUT1 and GLUT4 in the blood-brain barrier of the rat ventromedial hypothalamus. Brain Res. 2001;900:1–8.11325341Nigrovic LE, Kimia AA, Shah SS, Neuman MI. Relationship between cerebrospinal fluid glucose and serum glucose. N Engl J Med. 2012;366:576–578. doi: 10.1056/NEJMc1111080.10.1056/NEJMc111108022316468Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet. 2005;20:452–477.16415531Nishimura H, Pallardo FV, Seidner GA, Vannucci S, Simpson IA, Birnbaum MJ. Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. J Biol Chem. 1993;268:8514–8520.8473295Nour M, Scalzo F, Liebeskind DS. Ischemia-reperfusion injury in stroke. Interv Neurol. 2013;1:185–199.PMC403177725187778Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med. 2002;8:1376–1382. doi: 10.1038/nm1202-798.10.1038/nm1202-79812426561O'Donnell ME, Tran L, Lam TI, Liu XB, Anderson SE. Bumetanide inhibition of the blood-brain barrier Na-K-Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke. J Cereb Blood Flow Metab. 2004;24:1046–1056. doi: 10.1097/01.WCB.0000130867.32663.90.10.1097/01.WCB.0000130867.32663.9015356425O'Donnell ME, Lam TI, Tran LQ, Foroutan S, Anderson SE. Estradiol reduces activity of the blood-brain barrier Na-K-Cl cotransporter and decreases edema formation in permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab. 2006;26:1234–1249. doi: 10.1038/sj.jcbfm.9600278.10.1038/sj.jcbfm.960027816421506Oerter S, Forster C, Bohnert M (2018) Validation of sodium/glucose cotransporter proteins in human brain as a potential marker for temporal narrowing of the trauma formation. Int J Legal Med https://www.ncbi.nlm.nih.gov/pubmed/3007351030073510Ohtsuki S, Kikkawa T, Hori S, Terasaki T. Modulation and compensation of the mRNA expression of energy related transporters in the brain of glucose transporter 1-deficient mice. Biol Pharm Bull. 2006;29:1587–1591.16880609Oldendorf WH. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Phys. 1971;221:1629–1639. doi: 10.1152/ajplegacy.1971.221.6.1629.10.1152/ajplegacy.1971.221.6.16295124307O'Malley D, Reimann F, Simpson AK, Gribble FM. Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes. 2006;55:3381–3386. doi: 10.2337/db06-0531.10.2337/db06-0531PMC194897417130483Oomura Y, Yoshimatsu H. Neural network of glucose monitoring system. J Auton Nerv Syst. 1984;10:359–372.6090526Oomura Y, Ono T, Ooyama H, Wayner MJ. Glucose and osmosensitive neurones of the rat hypothalamus. Nature. 1969;222:282–284. doi: 10.1038/222282a0.10.1038/222282a05778398Oppelt SA, Zhang W, Tolan DR. Specific regions of the brain are capable of fructose metabolism. Brain Res. 2017;1657:312–322. doi: 10.1016/j.brainres.2016.12.022.10.1016/j.brainres.2016.12.022PMC542042728034722Orellana JA, Saez PJ, Cortes-Campos C, Elizondo RJ, Shoji KF, Contreras-Duarte S, Figueroa V, Velarde V, Jiang JX, Nualart F, Saez JC, Garcia MA. Glucose increases intracellular free Ca(2+) in tanycytes via ATP released through connexin 43 hemichannels. Glia. 2012;60:53–68. doi: 10.1002/glia.21246.10.1002/glia.21246PMC341733021987367Osswald C, Baumgarten K, Stümpel F, Gorboulev V, Akimjanova M, Knobeloch K-P, Horak I, Kluge R, Joost H-G, Koepsell H. Mice without the regulator gene Rsc1A1 exhibit increased Na+-D-glucose cotransport in small intestine and develop obesity. Mol Cell Biol. 2005;25:78–87.PMC53875715601832Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53:1937–1942. doi: 10.1212/wnl.53.9.1937.10.1212/wnl.53.9.193710599761Page KA, Chan O, Arora J, Belfort-Deaguiar R, Dzuira J, Roehmholdt B, Cline GW, Naik S, Sinha R, Constable RT, Sherwin RS. Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA. 2013;309:63–70. doi: 10.1001/jama.2012.116975.10.1001/jama.2012.116975PMC407614523280226Paranjape SA, Chan O, Zhu W, Horblitt AM, McNay EC, Cresswell JA, Bogan JS, McCrimmon RJ, Sherwin RS. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes. 2010;59:1521–1527. doi: 10.2337/db10-0014.10.2337/db10-0014PMC287471420299468Pardridge WM, Triguero D, Farrell CR. Downregulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes. 1990;39:1040–1044. doi: 10.2337/diab.39.9.1040.10.2337/diab.39.9.10402384187Park E, Bell JD, Siddiq IP, Baker AJ. An analysis of regional microvascular loss and recovery following two grades of fluid percussion trauma: a role for hypoxia-inducible factors in traumatic brain injury. J Cereb Blood Flow Metab. 2009;29:575–584. doi: 10.1038/jcbfm.2008.151.10.1038/jcbfm.2008.15119088740Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY, Xu C, Vianna CR, Balthasar N, Lee CE, Elmquist JK, Cowley MA, Lowell BB. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature. 2007;449:228–232. doi: 10.1038/nature06098.10.1038/nature0609817728716Pascual JM, Ronen GM. Glucose transporter type I deficiency (G1D) at 25 (1990-2015): presumptions, facts, and the lives of persons with this rare disease. Pediatr Neurol. 2015;53:379–393. doi: 10.1016/j.pediatrneurol.2015.08.001.10.1016/j.pediatrneurol.2015.08.001PMC460961026341673Pascual JM, Van Heertum RL, Wang D, Engelstad K, De Vivo DC. Imaging the metabolic footprint of Glut1 deficiency on the brain. Ann Neurol. 2002;52:458–464.12325075Patching SG. Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery. Mol Neurobiol. 2017;54:1046–1077. doi: 10.1007/s12035-015-9672-6.10.1007/s12035-015-9672-626801191Patel SS, Gupta S, Udayabanu M. Urtica dioica modulates hippocampal insulin signaling and recognition memory deficit in streptozotocin induced diabetic mice. Metab Brain Dis. 2016;31:601–611. doi: 10.1007/s11011-016-9791-4.10.1007/s11011-016-9791-426767366Payne J, Maher F, Simpson I, Mattice L, Davies P. Glucose transporter Glut 5 expression in microglial cells. Glia. 1997;21:327–331. doi: 10.1002/(sici)1098-1136(199711)21:3<327::aid-glia7>3.0.co;2-1.10.1002/(sici)1098-1136(199711)21:3<327::aid-glia7>3.0.co;2-19383041Pearson-Leary J, McNay EC. Novel roles for the insulin-regulated glucose transporter-4 in hippocampally dependent memory. J Neurosci. 2016;36:11851–11864. doi: 10.1523/JNEUROSCI.1700-16.2016.10.1523/JNEUROSCI.1700-16.2016PMC512524427881773Pearson-Leary J, Jahagirdar V, Sage J, McNay EC. Insulin modulates hippocampally-mediated spatial working memory via glucose transporter-4. Behav Brain Res. 2018;338:32–39. doi: 10.1016/j.bbr.2017.09.033.10.1016/j.bbr.2017.09.033PMC568187828943428Pellerin L, Magistretti PJ. Food for thought: challenging the dogmas. J Cereb Blood Flow Metab. 2003;23:1282–1286. doi: 10.1097/01.WCB.0000096064.12129.3D.10.1097/01.WCB.0000096064.12129.3D14600434Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE. Diminished glucose transport and phosphorylation in Alzheimer’s disease determined by dynamic FDG-PET. J Nucl Med. 1996;37:201–208.8667045Pintana H, Apaijai N, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Life Sci. 2012;91:409–414. doi: 10.1016/j.lfs.2012.08.017.10.1016/j.lfs.2012.08.01722925597Pintana H, Apaijai N, Chattipakorn N, Chattipakorn SC. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. J Endocrinol. 2013;218:1–11. doi: 10.1530/JOE-12-0521.10.1530/JOE-12-052123591914Pipatpiboon N, Pintana H, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. Eur J Neurosci. 2013;37:839–849. doi: 10.1111/ejn.12088.10.1111/ejn.1208823240760Piroli GG, Grillo CA, Hoskin EK, Znamensky V, Katz EB, Milner TA, McEwen BS, Charron MJ, Reagan LP. Peripheral glucose administration stimulates the translocation of GLUT8 glucose transporter to the endoplasmic reticulum in the rat hippocampus. J Comp Neurol. 2002;452:103–114. doi: 10.1002/cne.10368.10.1002/cne.1036812271485Poppe R, Karbach U, Gambaryan S, Wiesinger H, Lutzenburg M, Kraemer M, Witte OW, Koepsell H. Expression of the Na+-D-glucose cotransporter SGLT1 in neurons. J Neurochem. 1997;69:84–94.9202297Porras OH, Ruminot I, Loaiza A, Barros LF. Na(+)-Ca(2+) cosignaling in the stimulation of the glucose transporter GLUT1 in cultured astrocytes. Glia. 2008;56:59–68. doi: 10.1002/glia.20589.10.1002/glia.2058917924581Pouliot JF, Beliveau R. Palmitoylation of the glucose transporter in blood-brain barrier capillaries. Biochim Biophys Acta. 1995;1234:191–196.7696293Prevot V, Dehouck B, Sharif A, Ciofi P, Giacobini P, Clasadonte J. The versatile tanycyte: a hypothalamic integrator of reproduction and energy metabolism. Endocr Rev. 2018;39:333–368. doi: 10.1210/er.2017-00235.10.1210/er.2017-0023529351662Prichard J, Rothman D, Novotny E, Petroff O, Kuwabara T, Avison M, Howseman A, Hanstock C, Shulman R. Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci U S A. 1991;88:5829–5831. doi: 10.1073/pnas.88.13.5829.10.1073/pnas.88.13.5829PMC519712062861Prohovnik I, Mayeux R, Sackeim HA, Smith G, Stern Y, Alderson PO. Cerebral perfusion as a diagnostic marker of early Alzheimer’s disease. Neurology. 1988;38:931–937. doi: 10.1212/wnl.38.6.931.10.1212/wnl.38.6.9313368076Puchowicz MA, Xu K, Magness D, Miller C, Lust WD, Kern TS, LaManna JC. Comparison of glucose influx and blood flow in retina and brain of diabetic rats. J Cereb Blood Flow Metab. 2004;24:449–457. doi: 10.1097/00004647-200404000-00010.10.1097/00004647-200404000-0001015087714Rafiki A, Boulland JL, Halestrap AP, Ottersen OP, Bergersen L. Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain. Neuroscience. 2003;122:677–688. doi: 10.1016/j.neuroscience.2003.08.040.10.1016/j.neuroscience.2003.08.04014622911Rangaraju V, Calloway N, Ryan TA. Activity-driven local ATP synthesis is required for synaptic function. Cell. 2014;156:825–835. doi: 10.1016/j.cell.2013.12.042.10.1016/j.cell.2013.12.042PMC395517924529383Reagan LP. Neuronal insulin signal transduction mechanisms in diabetes phenotypes. Neurobiol Aging. 2005;26(Suppl 1):56–59. doi: 10.1016/j.neurobiolaging.2005.09.001.10.1016/j.neurobiolaging.2005.09.00116225964Reagan LP, Magarinos AM, McEwen BS. Neurological changes induced by stress in streptozotocin diabetic rats. Ann N Y Acad Sci. 1999;893:126–137.10672234Reagan LP, Gorovits N, Hoskin EK, Alves SE, Katz EB, Grillo CA, Piroli GG, McEwen BS, Charron MJ. Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats. Proc Natl Acad Sci U S A. 2001;98:2820–2825. doi: 10.1073/pnas.051629798.10.1073/pnas.051629798PMC3022311226324Regina A, Morchoisne S, Borson ND, McCall AL, Drewes LR, Roux F. Factor(s) released by glucose-deprived astrocytes enhance glucose transporter expression and activity in rat brain endothelial cells. Biochim Biophys Acta. 2001;1540:233–242.11583818Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc Natl Acad Sci U S A. 2004;101:284–289. doi: 10.1073/pnas.2635903100.10.1073/pnas.2635903100PMC31417714688411Reitz C. Alzheimer’s disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimers Dis. 2012;2012:369808. doi: 10.1155/2012/369808.10.1155/2012/369808PMC331357322506132Ren H, Lu TY, McGraw TE, Accili D. Anorexia and impaired glucose metabolism in mice with hypothalamic ablation of Glut4 neurons. Diabetes. 2015;64:405–417. doi: 10.2337/db14-0752.10.2337/db14-0752PMC430397025187366Reno CM, Puente EC, Sheng Z, Daphna-Iken D, Bree AJ, Routh VH, Kahn BB, Fisher SJ. Brain GLUT4 knockout mice have impaired glucose tolerance, decreased insulin sensitivity, and impaired hypoglycemic counterregulation. Diabetes. 2017;66:587–597. doi: 10.2337/db16-0917.10.2337/db16-0917PMC531972027797912Ritter S, Strang M. Fourth ventricular alloxan injection causes feeding but not hyperglycemia in rats. Brain Res. 1982;249:198–201. doi: 10.1016/0006-8993(82)90190-1.10.1016/0006-8993(82)90190-17139297Ritter RC, Slusser PG, Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science. 1981;213:451–452. doi: 10.1126/science.6264602.10.1126/science.62646026264602Ritter S, Li AJ, Wang Q, Dinh TT. Minireview: the value of looking backward: the essential role of the hindbrain in counterregulatory responses to glucose deficit. Endocrinology. 2011;152:4019–4032. doi: 10.1210/en.2010-1458.10.1210/en.2010-1458PMC344496721878511Rivas CI, Zuniga FA, Salas-Burgos A, Mardones L, Ormazabal V, Vera JC. Vitamin C transporters. J Physiol Biochem. 2008;64:357–375. doi: 10.1007/bf03174092.10.1007/bf0317409219391462Rodriguez EM, Blazquez JL, Pastor FE, Pelaez B, Pena P, Peruzzo B, Amat P. Hypothalamic tanycytes: a key component of brain-endocrine interaction. Int Rev Cytol. 2005;247:89–164. doi: 10.1016/S0074-7696(05)47003-5.10.1016/S0074-7696(05)47003-516344112Romine J, Gao X, Chen J (2014) Controlled cortical impact model for traumatic brain injury. J Vis Exp e51781 https://www.ncbi.nlm.nih.gov/pubmed/25145417PMC467295325145417Rotstein M, Engelstad K, Yang H, Wang D, Levy B, Chung WK, De Vivo DC. Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann Neurol. 2010;68:955–958. doi: 10.1002/ana.22088.10.1002/ana.22088PMC299498820687207Routh VH. Glucose-sensing neurons: are they physiologically relevant? Physiol Behav. 2002;76:403–413. doi: 10.1016/s0031-9384(02)00761-8.10.1016/s0031-9384(02)00761-812117577Rovet JF, Ehrlich RM, Hoppe M. Intellectual deficits associated with early onset of insulin-dependent diabetes mellitus in children. Diabetes Care. 1987;10:510–515. doi: 10.2337/diacare.10.4.510.10.2337/diacare.10.4.5103622209Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery. 2000;46:335–342.10690722Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Ann Neurol. 2005;57:789–794. doi: 10.1002/ana.20493.10.1002/ana.2049315929050Ruminot I, Gutierrez R, Pena-Munzenmayer G, Anazco C, Sotelo-Hitschfeld T, Lerchundi R, Niemeyer MI, Shull GE, Barros LF. NBCe1 mediates the acute stimulation of astrocytic glycolysis by extracellular K+ J Neurosci. 2011;31:14264–14271. doi: 10.1523/JNEUROSCI.2310-11.2011.10.1523/JNEUROSCI.2310-11.2011PMC320029321976511Ryan C, Vega A, Drash A. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics. 1985;75:921–927.3991281Sabolic I, Vrhovac I, Eror DB, Gerasimova M, Rose M, Breljak D, Ljubojevic M, Brzica H, Sebastiani A, Thal SC, Sauvant C, Kipp H, Vallon V, Koepsell H. Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences. Am J Physiol Cell Physiol. 2012;302:C1174–C1188. doi: 10.1152/ajpcell.00450.2011.10.1152/ajpcell.00450.2011PMC377455322262063Sagare AP, Bell RD, Zlokovic BV (2012) Neurovascular dysfunction and faulty amyloid beta-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med 2. 10.1101/cshperspect.a011452PMC347540523028132Sage JM, Carruthers A. Human erythrocytes transport dehydroascorbic acid and sugars using the same transporter complex. Am J Physiol Cell Physiol. 2014;306:C910–C917. doi: 10.1152/ajpcell.00044.2014.10.1152/ajpcell.00044.2014PMC402471224598365Sankar R, Thamotharan S, Shin D, Moley KH, Devaskar SU. Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain. Brain Res Mol Brain Res. 2002;107:157–165.12425944Schmidt S, Gawlik V, Holter SM, Augustin R, Scheepers A, Behrens M, Wurst W, Gailus-Durner V, Fuchs H, Hrabe de Angelis M, Kluge R, Joost HG, Schurmann A. Deletion of glucose transporter GLUT8 in mice increases locomotor activity. Behav Genet. 2008;38:396–406. doi: 10.1007/s10519-008-9208-1.10.1007/s10519-008-9208-1PMC248059618461434Schmidt S, Joost HG, Schurmann A. GLUT8, the enigmatic intracellular hexose transporter. Am J Physiol Endocrinol Metab. 2009;296:E614–E618. doi: 10.1152/ajpendo.91019.2008.10.1152/ajpendo.91019.200819176349Sebastiani A, Greve F, Golz C, Forster CY, Koepsell H, Thal SC. RS1 (Rsc1A1) deficiency limits cerebral SGLT1 expression and delays brain damage after experimental traumatic brain injury. J Neurochem. 2018;147:190–203. doi: 10.1111/jnc.14551.10.1111/jnc.1455130022488Seidner G, Alvarez MG, Yeh J-I, O'Driscoll KR, Klepper J, Stump TS, Wang D, Spinner NB, Birnbaum MJ, De Vivo DC. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet. 1998;18:188–191.9462754Selkoe DJ. Alzheimer’s disease is a synaptic failure. Science. 2002;298:789–791. doi: 10.1126/science.1074069.10.1126/science.107406912399581Shah K, Desilva S, Abbruscato T. The role of glucose transporters in brain disease: diabetes and Alzheimer’s disease. Int J Mol Sci. 2012;13:12629–12655. doi: 10.3390/ijms131012629.10.3390/ijms131012629PMC349729223202918Shein NA, Horowitz M, Alexandrovich AG, Tsenter J, Shohami E. Heat acclimation increases hypoxia-inducible factor 1alpha and erythropoietin receptor expression: implication for neuroprotection after closed head injury in mice. J Cereb Blood Flow Metab. 2005;25:1456–1465. doi: 10.1038/sj.jcbfm.9600142.10.1038/sj.jcbfm.960014215902197Shepherd PR, Gibbs EM, Wesslau C, Gould GW, Kahn BB. Human small intestine facilitative fructose/glucose transporter (GLUT5) is also present in insulin-responsive tissues and brain. Investigation of biochemical characteristics and translocation. Diabetes. 1992;41:1360–1365. doi: 10.2337/diab.41.10.1360.10.2337/diab.41.10.13601397712Shepherd PR, Gould GW, Colville CA, McCoid SC, Gibbs EM, Kahn BB. Distribution of GLUT3 glucose transporter protein in human tissues. Biochem Biophys Res Commun. 1992;188:149–154.1417839Shi J, Simpkins JW. 17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am J Phys. 1997;272:E1016–E1022. doi: 10.1152/ajpendo.1997.272.6.E1016.10.1152/ajpendo.1997.272.6.E10169227446Shi J, Zhang YQ, Simpkins JW. Effects of 17beta-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats. Exp Brain Res. 1997;117:200–206. doi: 10.1007/s002210050216.10.1007/s0022100502169419067Shin BC, McKnight RA, Devaskar SU. Glucose transporter GLUT8 translocation in neurons is not insulin responsive. J Neurosci Res. 2004;75:835–844. doi: 10.1002/jnr.20054.10.1002/jnr.2005414994344Shiraishi T. Noradrenergic neurons modulate lateral hypothalamic chemical and electrical stimulation-induced feeding by sated rats. Brain Res Bull. 1991;27:347–351. doi: 10.1016/0361-9230(91)90123-2.10.1016/0361-9230(91)90123-21959029Shu HJ, Isenberg K, Cormier RJ, Benz A, Zorumski CF. Expression of fructose sensitive glucose transporter in the brains of fructose-fed rats. Neuroscience. 2006;140:889–895. doi: 10.1016/j.neuroscience.2006.02.071.10.1016/j.neuroscience.2006.02.07116581195Silver IA, Erecinska M. Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J Neurosci. 1994;14:5068–5076.PMC65771718046468Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer’s disease. Ann Neurol. 1994;35:546–551. doi: 10.1002/ana.410350507.10.1002/ana.4103505078179300Simpson IA, Vannucci SJ, DeJoseph MR, Hawkins RA. Glucose transporter asymmetries in the bovine blood-brain barrier. J Biol Chem. 2001;276:12725–12729.11278779Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab. 2007;27:1766–1791. doi: 10.1038/sj.jcbfm.9600521.10.1038/sj.jcbfm.9600521PMC209410417579656Simpson IA, Dwyer D, Malide D, Moley KH, Travis A, Vannucci SJ. The facilitative glucose transporter GLUT3: 20 years of distinction. Am J Physiol Endocrinol Metab. 2008;295:E242–E253. doi: 10.1152/ajpendo.90388.2008.10.1152/ajpendo.90388.2008PMC251975718577699Smith GS, de Leon MJ, George AE, Kluger A, Volkow ND, McRae T, Golomb J, Ferris SH, Reisberg B, Ciaravino J, et al. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer’s disease. Pathophysiologic implications. Arch Neurol. 1992;49:1142–1150. doi: 10.1001/archneur.1992.00530350056020.10.1001/archneur.1992.005303500560201444881Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, Avison MJ. Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease. Neurology. 1999;53:1391–1396. doi: 10.1212/wnl.53.7.1391.10.1212/wnl.53.7.139110534240Sogin DC, Hinkle PC. Immunological identification of the human erythrocyte glucose transporter. Proc Natl Acad Sci U S A. 1980;77:5725–5729. doi: 10.1073/pnas.77.10.5725.10.1073/pnas.77.10.5725PMC3501426934506Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897–916. doi: 10.1111/j.1471-4159.1977.tb10649.x.10.1111/j.1471-4159.1977.tb10649.x864466Sprague JE, Arbelaez AM. Glucose counterregulatory responses to hypoglycemia. Pediatr Endocrinol Rev. 2011;9:463–473.PMC375537722783644Steffens AB, Scheurink AJ, Luiten PG, Bohus B. Hypothalamic food intake regulating areas are involved in the homeostasis of blood glucose and plasma FFA levels. Physiol Behav. 1988;44:581–589. doi: 10.1016/0031-9384(88)90322-8.10.1016/0031-9384(88)90322-83070585Steffens AB, Scheurink AJ, Porte D, Jr, Woods SC. Penetration of peripheral glucose and insulin into cerebrospinal fluid in rats. Am J Phys. 1988;255:R200–R204. doi: 10.1152/ajpregu.1988.255.2.R200.10.1152/ajpregu.1988.255.2.R2003044143Stolarczyk E, Guissard C, Michau A, Even PC, Grosfeld A, Serradas P, Lorsignol A, Penicaud L, Brot-Laroche E, Leturque A, Le Gall M. Detection of extracellular glucose by GLUT2 contributes to hypothalamic control of food intake. Am J Physiol Endocrinol Metab. 2010;298:E1078–E1087. doi: 10.1152/ajpendo.00737.2009.10.1152/ajpendo.00737.200920179244Stuart CA, Ross IR, Howell ME, McCurry MP, Wood TG, Ceci JD, Kennel SJ, Wall J. Brain glucose transporter (Glut3) haploinsufficiency does not impair mouse brain glucose uptake. Brain Res. 2011;1384:15–22. doi: 10.1016/j.brainres.2011.02.014.10.1016/j.brainres.2011.02.014PMC306964621316350Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ, Alberini CM. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell. 2011;144:810–823. doi: 10.1016/j.cell.2011.02.018.10.1016/j.cell.2011.02.018PMC307383121376239Takimoto M, Hamada T (2014) Acute exercise increases brain region-specific expression of MCT1, MCT2, MCT4, GLUT1, and COX IV proteins. J Appl Physiol (1985) 116:1238–1250. 10.1152/japplphysiol.01288.2013, https://www.ncbi.nlm.nih.gov/pubmed/2461053224610532Tanegashima K, Sato-Miyata Y, Funakoshi M, Nishito Y, Aigaki T, Hara T. Epigenetic regulation of the glucose transporter gene Slc2a1 by beta-hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice. Genes Cells. 2017;22:71–83. doi: 10.1111/gtc.12456.10.1111/gtc.1245627935189Tang J, Zhu XW, Lust WD, Kern TS. Retina accumulates more glucose than does the embryologically similar cerebral cortex in diabetic rats. Diabetologia. 2000;43:1417–1423. doi: 10.1007/s001250051548.10.1007/s00125005154811126412Tang M, Gao G, Rueda CB, Yu H, Thibodeaux DN, Awano T, Engelstad KM, Sanchez-Quintero MJ, Yang H, Li F, Li H, Su Q, Shetler KE, Jones L, Seo R, McConathy J, Hillman EM, Noebels JL, De Vivo DC, Monani UR. Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein. Nat Commun. 2017;8:14152. doi: 10.1038/ncomms14152.10.1038/ncomms14152PMC526388728106060Tazawa S, Yamato T, Fujikura H, Hiratochi M, Itoh F, Tomae M, Takemura Y, Maruyama H, Sugiyama T, Wakamatsu A, Isogai T, Isaji M. SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci. 2005;76:1039–1050.15607332Thompson BJ, Ronaldson PT. Drug delivery to the ischemic brain. Adv Pharmacol. 2014;71:165–202. doi: 10.1016/bs.apha.2014.06.013.10.1016/bs.apha.2014.06.013PMC428126625307217Thorens B. GLUT2 in pancreatic and extra-pancreatic gluco-detection (review) Mol Membr Biol. 2001;18:265–273.11780755Thorens B, Mueckler M. Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab. 2010;298:E141–E145. doi: 10.1152/ajpendo.00712.2009.10.1152/ajpendo.00712.2009PMC282248620009031Thurston JH, Levy CA, Warren SK, Jones EM. Permeability of the blood-brain barrier to fructose and the anaerobic use of fructose in the brains of young mice. J Neurochem. 1972;19:1685–1696. doi: 10.1111/j.1471-4159.1972.tb06213.x.10.1111/j.1471-4159.1972.tb06213.x5042471Tomioka S. Water transport by glucose transporter type 3 expressed in Xenopus oocytes. Neuroreport. 2012;23:21–25. doi: 10.1097/WNR.0b013e32834da877.10.1097/WNR.0b013e32834da87722113212Tong Q, Ye C, McCrimmon RJ, Dhillon H, Choi B, Kramer MD, Yu J, Yang Z, Christiansen LM, Lee CE, Choi CS, Zigman JM, Shulman GI, Sherwin RS, Elmquist JK, Lowell BB. Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab. 2007;5:383–393. doi: 10.1016/j.cmet.2007.04.001.10.1016/j.cmet.2007.04.001PMC193492617488640Tsujii S, Bray GA. Effects of glucose, 2-deoxyglucose, phlorizin, and insulin on food intake of lean and fatty rats. Am J Phys. 1990;258:E476–E481.2180317Uemura E, Greenlee HW. Amyloid beta-peptide inhibits neuronal glucose uptake by preventing exocytosis. Exp Neurol. 2001;170:270–276. doi: 10.1006/exnr.2001.7719.10.1006/exnr.2001.771911476592Ueno M, Nishi N, Nakagawa T, Chiba Y, Tsukamoto I, Kusaka T, Miki T, Sakamoto H, Yamaguchi F, Tokuda M. Immunoreactivity of glucose transporter 5 is located in epithelial cells of the choroid plexus and ependymal cells. Neuroscience. 2014;260:149–157. doi: 10.1016/j.neuroscience.2013.12.006.10.1016/j.neuroscience.2013.12.00624361738Uldry M, Ibberson M, Hosokawa M, Thorens B. GLUT2 is a high affinity glucosamine transporter. FEBS Lett. 2002;524:199–203.12135767Ullner PM, Di Nardo A, Goldman JE, Schobel S, Yang H, Engelstad K, Wang D, Sahin M, De Vivo DC. Murine Glut-1 transporter haploinsufficiency: postnatal deceleration of brain weight and reactive astrocytosis. Neurobiol Dis. 2009;36:60–69. doi: 10.1016/j.nbd.2009.06.014.10.1016/j.nbd.2009.06.014PMC292970719591936Umscheif G, Shein NA, Alexandrovich AG, Trembovler V, Horowitz M, Shohami E. Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury. J Cereb Blood Flow Metab. 2010;30:616–627. doi: 10.1038/jcbfm.2009.234.10.1038/jcbfm.2009.234PMC294913419904288Umschweif G, Alexandrovich AG, Trembovler V, Horowitz M, Shohami E. Hypoxia-inducible factor 1 is essential for spontaneous recovery from traumatic brain injury and is a key mediator of heat acclimation induced neuroprotection. J Cereb Blood Flow Metab. 2013;33:524–531. doi: 10.1038/jcbfm.2012.193.10.1038/jcbfm.2012.193PMC361838623281425Unger J, McNeill TH, Moxley RT, 3rd, White M, Moss A, Livingston JN. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience. 1989;31:143–157. doi: 10.1016/0306-4522(89)90036-5.10.1016/0306-4522(89)90036-52771055Urabe T, Hattori N, Nagamatsu S, Sawa H, Mizuno Y. Expression of glucose transporters in rat brain following transient focal ischemic injury. J Neurochem. 1996;67:265–271.8667001Vagnozzi R, Marmarou A, Tavazzi B, Signoretti S, Di Pierro D, del Bolgia F, Amorini AM, Fazzina G, Sherkat S, Lazzarino G. Changes of cerebral energy metabolism and lipid peroxidation in rats leading to mitochondrial dysfunction after diffuse brain injury. J Neurotrauma. 1999;16:903–913. doi: 10.1089/neu.1999.16.903.10.1089/neu.1999.16.90310547099Valladolid-Acebes I, Stucchi P, Cano V, Fernandez-Alfonso MS, Merino B, Gil-Ortega M, Fole A, Morales L, Ruiz-Gayo M, Del Olmo N. High-fat diets impair spatial learning in the radial-arm maze in mice. Neurobiol Learn Mem. 2011;95:80–85. doi: 10.1016/j.nlm.2010.11.007.10.1016/j.nlm.2010.11.00721093599van de Ven KC, van der Graaf M, Tack CJ, Heerschap A, de Galan BE. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes. 2012;61:1974–1977. doi: 10.2337/db11-1778.10.2337/db11-1778PMC340232022688331van den Top M, Spanswick D. Integration of metabolic stimuli in the hypothalamic arcuate nucleus. Prog Brain Res. 2006;153:141–154. doi: 10.1016/S0079-6123(06)53008-0.10.1016/S0079-6123(06)53008-016876573van der Graaf M, Janssen SW, van Asten JJ, Hermus AR, Sweep CG, Pikkemaat JA, Martens GJ, Heerschap A. Metabolic profile of the hippocampus of Zucker diabetic fatty rats assessed by in vivo 1H magnetic resonance spectroscopy. NMR Biomed. 2004;17:405–410. doi: 10.1002/nbm.896.10.1002/nbm.89615386626Vanderklish PW, Bahr BA. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol. 2000;81:323–339. doi: 10.1111/j.1365-2613.2000.00169.x.10.1111/j.1365-2613.2000.00169.xPMC251773811168679Vannucci SJ, Gibbs EM, Simpson IA. Glucose utilization and glucose transporter proteins GLUT-1 and GLUT-3 in brains of diabetic (db/db) mice. Am J Phys. 1997;272:E267–E274. doi: 10.1152/ajpendo.1997.272.2.E267.10.1152/ajpendo.1997.272.2.E2679124334Vannucci SJ, Koehler-Stec EM, Li K, Reynolds TH, Clark R, Simpson IA. GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res. 1998;797:1–11. doi: 10.1016/s0006-8993(98)00103-6.10.1016/s0006-8993(98)00103-69630471Vannucci SJ, Rutherford T, Wilkie MB, Simpson IA, Lauder JM. Prenatal expression of the GLUT4 glucose transporter in the mouse. Dev Neurosci. 2000;22:274–282. doi: 10.1159/000017451.10.1159/00001745110965149Vega C, Sachleben LR, Jr, Gozal D, Gozal E. Differential metabolic adaptation to acute and long-term hypoxia in rat primary cortical astrocytes. J Neurochem. 2006;97:872–883. doi: 10.1111/j.1471-4159.2006.03790.x.10.1111/j.1471-4159.2006.03790.x16573648Vemula S, Roder KE, Yang T, Bhat GJ, Thekkumkara TJ, Abbruscato TJ. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J Pharmacol Exp Ther. 2009;328:487–495.PMC263037118981287Vera JC, Rivas CI, Velasquez FV, Zhang RH, Concha II, Golde DW. Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid. J Biol Chem. 1995;270:23706–23712. doi: 10.1074/jbc.270.40.23706.10.1074/jbc.270.40.237067559541Vogelsang P, Giil LM, Lund A, Vedeler CA, Parkar AP, Nordrehaug JE, Kristoffersen EK. Reduced glucose transporter-1 in brain derived circulating endothelial cells in mild Alzheimer’s disease patients. Brain Res. 2018;1678:304–309. doi: 10.1016/j.brainres.2017.10.035.10.1016/j.brainres.2017.10.03529102777Vorbrodt AW, Dobrogowska DH, Meeker HC, Carp RI. Immunogold study of regional differences in the distribution of glucose transporter (GLUT-1) in mouse brain associated with physiological and accelerated aging and scrapie infection. J Neurocytol. 1999;28:711–719. doi: 10.1023/a:1007034003114.10.1023/a:100703400311410859574Vorbrodt AW, Dobrogowska DH, Tarnawski M. Immunogold study of interendothelial junction-associated and glucose transporter proteins during postnatal maturation of the mouse blood-brain barrier. J Neurocytol. 2001;30:705–716. doi: 10.1023/a:1016581801188.10.1023/a:101658180118812118158Voss AA, Diez-Sampedro A, Hirayama BA, Loo DDF, Wright EM. Imino sugars are potent agonists of the human glucose sensor SGLT3. Mol Pharmacol. 2007;71:628–634.17110502Wallum BJ, Taborsky GJ, Jr, Porte D, Jr, Figlewicz DP, Jacobson L, Beard JC, Ward WK, Dorsa D. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab. 1987;64:190–194. doi: 10.1210/jcem-64-1-190.10.1210/jcem-64-1-1903536982Wan HZ, Hulsey MG, Martin RJ. Intracerebroventricular administration of antisense oligodeoxynucleotide against GLUT2 glucose transporter mRNA reduces food intake, body weight change and glucoprivic feeding response in rats. J Nutr. 1998;128:287–291. doi: 10.1093/jn/128.2.287.10.1093/jn/128.2.2879446857Wang D, Pascual JM, Yang H, Engelstad K, Mao X, Cheng J, Yoo J, Noebels JL, De Vivo DC. A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet. 2006;15:1169–1179. doi: 10.1093/hmg/ddl032.10.1093/hmg/ddl03216497725Wang X, Xing A, Xu C, Cai Q, Liu H, Li L. Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-beta oligomerization in rats. J Alzheimers Dis. 2010;21:813–822. doi: 10.3233/JAD-2010-100216.10.3233/JAD-2010-10021620634588Wang L, Pavlou S, Du X, Bhuckory M, Xu H, Chen M. Glucose transporter 1 critically controls microglial activation through facilitating glycolysis. Mol Neurodegener. 2019;14:2. doi: 10.1186/s13024-019-0305-9.10.1186/s13024-019-0305-9PMC632907130634998Ward MW, Huber HJ, Weisova P, Dussmann H, Nicholls DG, Prehn JH. Mitochondrial and plasma membrane potential of cultured cerebellar neurons during glutamate-induced necrosis, apoptosis, and tolerance. J Neurosci. 2007;27:8238–8249. doi: 10.1523/JNEUROSCI.1984-07.2007.10.1523/JNEUROSCI.1984-07.2007PMC667304617670970Weber B, Barros LF (2015) The astrocyte: powerhouse and recycling center. Cold Spring Harb Perspect Biol 7. 10.1101/cshperspect.a020396PMC466507625680832Weisova P, Concannon CG, Devocelle M, Prehn JH, Ward MW. Regulation of glucose transporter 3 surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons. J Neurosci. 2009;29:2997–3008. doi: 10.1523/JNEUROSCI.0354-09.2009.10.1523/JNEUROSCI.0354-09.2009PMC666620219261894Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007;99:4–9. doi: 10.1093/bja/aem131.10.1093/bja/aem13117573392Wheeler TJ, Hinkle PC. Kinetic properties of the reconstituted glucose transporter from human erythrocytes. J Biol Chem. 1981;256:8907–8914.6455434Wheeler TJ, Cole D, Hauck MA. Characterization of glucose transport activity reconstituted from heart and other tissues. Biochim Biophys Acta. 1998;1414:217–230. doi: 10.1016/s0005-2736(98)00170-9.10.1016/s0005-2736(98)00170-99804957White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, Masaki K, Launer L, Markesbery WR. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci. 2002;977:9–23. doi: 10.1111/j.1749-6632.2002.tb04794.x.10.1111/j.1749-6632.2002.tb04794.x12480729Widmer M, Uldry M, Thorens B. GLUT8 subcellular localization and absence of translocation to the plasma membrane in PC12 cells and hippocampal neurons. Endocrinology. 2005;146:4727–4736. doi: 10.1210/en.2005-0668.10.1210/en.2005-066816109784Wieczorke R, Dlugai S, Krampe S, Boles E. Characterisation of mammalian GLUT glucose transporters in a heterologous yeast expression system. Cell Physiol Biochem. 2003;13:123–134. doi: 10.1159/000071863.10.1159/00007186312876383Willemsen MA, Vissers LE, Verbeek MM, van Bon BW, Geuer S, Gilissen C, Klepper J, Kwint MP, Leen WG, Pennings M, Wevers RA, Veltman JA, Kamsteeg EJ. Upstream SLC2A1 translation initiation causes GLUT1 deficiency syndrome. Eur J Hum Genet. 2017;25:771–774. doi: 10.1038/ejhg.2017.45.10.1038/ejhg.2017.45PMC547737228378819Williams RH, Alexopoulos H, Jensen LT, Fugger L, Burdakov D. Adaptive sugar sensors in hypothalamic feeding circuits. Proc Natl Acad Sci U S A. 2008;105:11975–11980. doi: 10.1073/pnas.0802687105.10.1073/pnas.0802687105PMC257530318695235Winocur G, Greenwood CE, Piroli GG, Grillo CA, Reznikov LR, Reagan LP, McEwen BS. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci. 2005;119:1389–1395. doi: 10.1037/0735-7044.119.5.1389.10.1037/0735-7044.119.5.138916300445Wright EM, Loo DDF, Hirayama BA. Biology of human sodium glucose transporters. Physiol Rev. 2011;91:733–794.21527736Wu N, Zheng B, Shaywitz A, Dagon Y, Tower C, Bellinger G, Shen CH, Wen J, Asara J, McGraw TE, Kahn BB, Cantley LC. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell. 2013;49:1167–1175. doi: 10.1016/j.molcel.2013.01.035.10.1016/j.molcel.2013.01.035PMC361514323453806Xia M, Ye Z, Shi Y, Zhou L, Hua Y. Curcumin improves diabetes mellitus associated cerebral infarction by increasing the expression of GLUT1 and GLUT3. Mol Med Rep. 2018;17:1963–1969. doi: 10.3892/mmr.2017.8085.10.3892/mmr.2017.808529257220Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, Tominaga M, Yagami K-i, Sugiyama F, Goto K, Yanagisawa M, Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron. 2003;38:701–713.12797956Yamazaki Y, Harada S, Tokuyama S. Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter. Brain Res. 2012;1489:113–120. doi: 10.1016/j.brainres.2012.10.020.10.1016/j.brainres.2012.10.02023078759Yamazaki Y, Harada S, Tokuyama S. Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemia. Neurosci Lett. 2015;604:134–139. doi: 10.1016/j.neulet.2015.08.004.10.1016/j.neulet.2015.08.00426254165Yamazaki Y, Ogihara S, Harada S, Tokuyama S. Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia. Neuroscience. 2015;310:674–685. doi: 10.1016/j.neuroscience.2015.10.005.10.1016/j.neuroscience.2015.10.00526454021Yamazaki Y, Harada S, Wada T, Yoshida S, Tokuyama S. Sodium transport through the cerebral sodium-glucose transporter exacerbates neuron damage during cerebral ischaemia. J Pharm Pharmacol. 2016;68:922–931. doi: 10.1111/jphp.12571.10.1111/jphp.1257127139580Yang X-j, Kow L-M, Funabashi T, Mobbs CV. Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms. Diabetes. 1999;48:1763–1772.10480606Yano H, Seino Y, Inagaki N, Hinokio Y, Yamamoto T, Yasuda K, Masuda K, Someya Y, Imura H. Tissue distribution and species difference of the brain type glucose transporter (GLUT3) Biochem Biophys Res Commun. 1991;174:470–477.1704223Yarchoan M, Arnold SE. Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes. 2014;63:2253–2261. doi: 10.2337/db14-0287.10.2337/db14-0287PMC406633524931035Yoshino A, Hovda DA, Kawamata T, Katayama Y, Becker DP. Dynamic changes in local cerebral glucose utilization following cerebral conclusion in rats: evidence of a hyper- and subsequent hypometabolic state. Brain Res. 1991;561:106–119. doi: 10.1016/0006-8993(91)90755-k.10.1016/0006-8993(91)90755-k1797338Yu S, Ding WG. The 45 kDa form of glucose transporter 1 (GLUT1) is localized in oligodendrocyte and astrocyte but not in microglia in the rat brain. Brain Res. 1998;797:65–72.9630522Yu AS, Hirayama BA, Timbol G, Liu J, Basarah E, Kepe V, Satyamurthy N, Huang S-C, Wright EM, Barrio JR. Functional expression of SGLTs in rat brain. Am J Physiol Cell Physiol. 2010;299:C1277–C1284. doi: 10.1152/ajpcell.00296.2010.10.1152/ajpcell.00296.2010PMC300632520826762Yu AS, Hirayama BA, Timbol G, Liu J, Diez-Sampedro A, Kepe V, Satyamurthy N, Huang SC, Wright EM, Barrio JR. Regional distribution of SGLT activity in rat brain in vivo. Am J Physiol Cell Physiol. 2013;304:C240–C247. doi: 10.1152/ajpcell.00317.2012.10.1152/ajpcell.00317.2012PMC356644123151803Yuan XQ, Prough DS, Smith TL, Dewitt DS. The effects of traumatic brain injury on regional cerebral blood flow in rats. J Neurotrauma. 1988;5:289–301. doi: 10.1089/neu.1988.5.289.10.1089/neu.1988.5.2893249308Yuzwa SA, Shan X, Jones BA, Zhao G, Woodward ML, Li X, Zhu Y, McEachern EJ, Silverman MA, Watson NV, Gong CX, Vocadlo DJ. Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice. Mol Neurodegener. 2014;9:42. doi: 10.1186/1750-1326-9-42.10.1186/1750-1326-9-42PMC423269725344697Zhang Z, Artelt M, Burnet M, Trautmann K, Schluesener HJ. Early infiltration of CD8+ macrophages/microglia to lesions of rat traumatic brain injury. Neuroscience. 2006;141:637–644. doi: 10.1016/j.neuroscience.2006.04.027.10.1016/j.neuroscience.2006.04.02716725271Zhang WW, Zhang L, Hou WK, Xu YX, Xu H, Lou FC, Zhang Y, Wang Q. Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion. Chin Med J. 2009;122:1996–2001.19781384Zhao W, Chen H, Xu H, Moore E, Meiri N, Quon MJ, Alkon DL. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem. 1999;274:34893–34902. doi: 10.1074/jbc.274.49.34893.10.1074/jbc.274.49.3489310574963Zhu Y, Shan X, Yuzwa SA, Vocadlo DJ. The emerging link between O-GlcNAc and Alzheimer disease. J Biol Chem. 2014;289:34472–34481. doi: 10.1074/jbc.R114.601351.10.1074/jbc.R114.601351PMC426385525336656Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR, Kahn BB. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med. 2000;6:924–928. doi: 10.1038/78693.10.1038/7869310932232Zlokovic BV. Neurovascular mechanisms of Alzheimer’s neurodegeneration. Trends Neurosci. 2005;28:202–208. doi: 10.1016/j.tins.2005.02.001.10.1016/j.tins.2005.02.00115808355Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178–201. doi: 10.1016/j.neuron.2008.01.003.10.1016/j.neuron.2008.01.00318215617Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci. 2011;12:723–738. doi: 10.1038/nrn3114.10.1038/nrn3114PMC403652022048062